Disclaimer: Despite efforts made to deliver this information, we cannot exclude inadvertent errors or omissions in this page. While every effort is made to ensure the accuracy of the information, it is not possible to guarantee that it is complete, accurate and up-to-date.
RMM_TECVAYLI_teclistamab_Patient card_L01FX24_EU/1/22/1675/001-2_25012024
RMM_PRADAXA_dabigatran etexilate_Prescriber guide_B01AE07_EU/1/08/442/001-030_29012024
RMM_LENALIDOMIDE GENERIS 15MG CAPSULES HARD_lenalidomide_Healthcare professionals' information pack_L04AX04_AA1500/00501_29012024
RMM_LENALIDOMIDE GENERIS 15MG CAPSULES HARD_lenalidomide_Patients' guide_L04AX04_AA1500/00501_29012024
RMM_LITFULO_ritlecitinib tosilate_Prescriber guide_L04AF08_EU/1/23/1755/001-3_31012024
RMM_LITFULO_ritlecitinib tosilate_Patient card_L04AF08_EU/1/23/1755/001-3_31012024
RMM_ZELVINA_lenalidomide_Guide for healthcare professionals_L04AX04_MA1339/00501-7_02022024
RMM_ZELVINA_lenalidomide_Checklist for healthcare professionals_L04AX04_MA1339/00501-7_02022024
RMM_ZELVINA_lenalidomide_Guide for patients_L04AX04_MA1339/00501-7_02022024
RMM_ZELVINA_lenalidomide_Patient card_L04AX04_MA1339/00501-7_02022024
RMM_ZELVINA_lenalidomide_Pregnancy reporting form_L04AX04_MA1339/00501-7_02022024
RMM_ATOMOXETINE ACCORD 25MG HARD CAPSULES_atomoxetine_Physician's guide_N06BA09_AA565/66607_19022024
RMM_KEYTRUDA_pembrolizumab_Patient card_L01FF02_EU/1/15/1024/002_19022024
RMM_ZOLEDRONIC ACID HIKMA 4MG/5ML CONCENTRATE FOR SOLUTION FOR INFUSION_zoledronic acid_Patient card_M05BA08_AA1454/02901_19022024
RMM_VORICONAZOLE NORMON 200MG POWDER FOR SOLUTION FOR INFUSION GSP_voriconazole_Patient card_J02AC03_AA1349/01501_04032024
RMM_MAVENCLAD_cladribine_Prescriber guide_L04AA40_EU/1/17/1212/001-6_06032024
RMM_MAVENCLAD_cladribine_Patient guide_L04AA40_EU/1/17/1212/001-6_06032024
RMM_OZURDEX_dexamethasone_Patient guide_S01BA01_EU/1/10/638/001_14032024
RMM_KINERET_anakinra_Guide for healthcare professionals_L04AC03_EU/1/02/203/005-7_14032024
RMM_KINERET_anakinra_Guide for patients_L04AC03_EU/1/02/203/005-7_14032024
RMM_LENALIDOMIDE DR. REDDY'S 2.5MG, 5MG, 7.5MG, 10MG, 15MG, 20MG, 25MG_lenalidomide_Guide for healthcare professionals_L04AX04_14032024
RMM_LENALIDOMIDE DR. REDDY'S 2.5MG, 5MG, 7.5MG, 10MG, 15MG, 20MG, 25MG_lenalidomide_Training presentation_L04AX04_14032024
RMM_LENALIDOMIDE DR. REDDY'S 2.5MG, 5MG, 7.5MG, 10MG, 15MG, 20MG, 25MG_lenalidomide_Treatment Initiation form for male patients_L04AX04_14032024
RMM_LENALIDOMIDE DR. REDDY'S 2.5MG, 5MG, 7.5Mg, 10MG, 15MG, 20MG, 25MG_lenalidomide_Treatment initiation form for women of child-bearing potential patients_L04AX04_14032024
RMM_LENALIDOMIDE DR. REDDY'S 2.5MG, 5MG, 7.5MG, 10Mg, 15MG, 20MG, 25MG_lenalidomide_Treatment initiation form for women of non-child-bearing potential patients_L04AX04_14032024
RMM_TYSABRI_natalizumab_Physician's information_L04AA23_EU/1/06/346/001-2_18032024
RMM_TYSABRI_natalizumab_Outside Administration Checklist_L04AA23_EU/1/06/346/001-2_18032024
RMM_TYSABRI_natalizumab_Treatment initiation and continuation forms_L04AA23_EU/1/06/346/001-2_18032024
RMM_TYSABRI_natalizumab_Discontinuation form_L04AA23_EU/1/06/346/001-2_18032024
RMM_TYSABRI_natalizumab_Patient card_L04AA23_EU/1/06/346/001-2_18032024
RMM_TYSABRI_natalizumab_Healthcare professional supplement information_L04AA23_EU/1/06/346/001-2_18032924
RMM_RINVOQ_upadacitinib_Healthcare professional guide_L04AA44_EU/1/19/1404/001-011_20032024
RMM_RINVOQ_upadacitinib_Patient card_L04AA44_EU/1/19/1404/001-011_20032024
RMM_CAMZYOS_mavacamten_Healthcare professionals' checklist_C01EB_EU/1/23/1716/001-012_25032024
RMM_CAMZYOS_mavacamten_Patients' guide_C01EB_EU/1/23/1716/001-012_25032024
RMM_CAMZYOS_mavacamten_Patient card_C01EB_EU/1/23/1716/001-012_25032024
RMM_ELREXFIO_elranatamab_Patient card_EU/1/23/1770/001-2_25032024
RMM_PRADAXA_dabigatran etexilate_SPAF_DVT_PE_Prescriber guide_B01AE01_EU/1/08/442/001-030_25032024
RMM_PRADAXA_dabigatran etexilate_VTE_Prescriber guide_B01AE01_EU/1/08/442/001-020_25032024
RMM_PIRFENIDONE CLONMEL 267MG, 801MG FILM-COATED TABLETS_pirfenidone_Safety checklist_L04AX05_AA1045/06801-2_08042024
RMM_ZYPADHERA_olanzapine_Training for healthcare professionals_N05AH03_EU/1/08/479/001-3_08042024
RMM_ZYPADHERA_olanzapine_Information for healthcare professionals_N05AH03_EU/1/08/479/001-3_08042024
RMM_ZYPADHERA_olanzapine_Patient card_N05AH03_EU/1/08/479/001-3_08042024
RMM_MIRENA IUD 20 MICROGRAM/24 HOURS_levonorgestrel_Guide for healthcare professionals_G02BA03_PI770/20201A_11042024
RMM_MIRENA IUD 20 MICROGRAM/24 HOURS_levonorgestrel_Patient card_G02BA03_PI770/20201A_11042024
RMM_ENHERTU_trastuzumab deruxtecan_Healthcare professional guide: important safety information on ILD/pneumonitis with treatment with Enhertu_L01FD04_EU/1/20/1508/001_17012023
RMM_ENHERTU_trastuzumab deruxtecan_Healthcare professional guide for the prevention of product confusion medication errors_L01FD04_EU/1/20/1508/001_17012023
RMM_RIVAROXABAN SANDOZ 10MG, 15MG, 20MG FILM-COATED TABLETS_rivaroxaban_Prescriber's guide_B01AF01_MA685/02901-3_19012023
RMM_RIVAROXABAN SANDOZ 10MG, 15MG, 20MG FILM-COATED TABLETS_rivaroxaban_Patient card_B01AF01_MA685/02901-3_19012023
RMM_XARELTO_rivaroxaban_Prescriber's guide_B01AF01_EU/1/08/472/001-051_06022023
RMM_ZOLEDRONIC ACID ALTAN 5MG/100ML SOLUTION FOR INFUSION_zoledronic acid_Patient card_M05BA08_AA1411/01801_06022023
RMM_MAYZENT_siponimod fumaric acid_Physician's checklist_L04AA42_EU/1/19/1414/001-8_23022023
RMM_MAYZENT_siponimod fumaric acid_Patient's and caregiver's guide_L04AA42_EU/1/19/1414/001-8_23022023
RMM_MAYZENT_siponimod fumaric acid_Gwida għall-pazjenti u kuraturi_L04AA42_EU/1/19/1414/001-8_23022023
RMM_MAYZENT_siponimod fumaric acid_Patient's card_L04AA42_EU/1/19/1414/001-8_23022023
RMM_MAYZENT_siponimod fumaric acid_Kartuna tal-pazjent_L04AA42_EU/1/19/1414/001-8_23022023
RMM_ZYPADHERA_olanzapine pamoate_Guide for healthcare professionals_N05AH03_EU/1/08/479/001-3_27022023
RMM_MYFORTIC 180MG/360MG GASTRO-RESISTANT TABLET_mycophenolic acid_Guide for healthcare providers_MA1249/00301-2_07032023
RMM_MYFORTIC 180MG/360MG GASTRO_RESISTANT TABLET_mycophenolic acid_Guide for patients_MA1249/00301-2_07032023
RMM_GILENYA_fingolimod hydrochloride_Physician's Checlist_L04AA27_EU/1/11/677/001-8_07032023
RMM_GILENYA_fingolimod hydrochloride_Patient guide_L04AA27_EU/1/11/677/001-8_07032023
RMM_GILENYA_fingolimod hydrochloride_Gwida għall-pazjent_L04AA27_EU/1/11/677/001-8_07032023
RMM_GILENYA_fingolimod hydrochloride_Parents and caregivers guide_L04AA27_EU/1/11/677/001-8_07032023
RMM_GILENYA_fingolimod hydrochloride_Gwida għall-ġenituri u l-kuraturi_L04AA27_EU/1/11/677/001-8_07032023
RMM_GILENYA_fingolimod hydrochloride_Pregnancy patient reminder card_L04AA27_EU/1/11/677/001-8_07032023
RMM_GILENYA_fingolimod hydrochloride_Kartuna li tfakkar lill-pazjenti specifikament dwar it-tqala_L04AA27_EU/1/11/677/001-8_07032023
RMM_UPTRAVI_selexipag_Guide for healthcare professionals_B01AC27_EU/1/15/1083/001-011_17032023
RMM_UPTRAVI_selexipag_Guide for patients_B01AC27_EU/1/15/1083/001-011_17032023
RMM_BEOVU_brolucizumab_Guide for patients_S01LA06_EU/1/19/1417/001-2_17032023
RMM_LUCENTIS_ranibizumab_Patient guide for the treatment of neovascular (wet) age-related macular degeneration (wAMD)_S01LA04_EU/1/06/374/002-4_17032023
RMM_LUCENTIS_ranibizumab_Patient guide for the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO)_S01LA04_EU/1/06/374/002-4_17032023
RMM_LUCENTIS_ranibizumab_Patient guide for the proliferative diabetic retinopathy (PDR) and/or visual impariment due to diabetic macular oedema (DME)_S01LA04_EU/1/06/374/002-4_17032023
RMM_LUCENTIS_ranibizumab_Patient guide for the visual impairment due to diabetic macular oedema (DME)_S01LA04_EU/1/06/374/002-4_17032023
RMM_LUCENTIS_ranibizumab_Patient guide for the visual impairment due to choroidal neovascularization (CNV)_S01LA04_ EU/1/06/374/002-4_17032023
RMM_ENTYVIO_vedolizumab_Guide for healthcare professionals_L04AA33_EU/1/14/923/001-7_17042023
RMM_XELJANZ_tofacitinib_Prescriber's guide_L04AA29_EU/1/17/1178/001-015_20042023
RMM_XELJANZ_tofacitinib_Prescriber's treatment initiation checklist_L04AA29_EU/1/17/1178/001-015_20042023
RMM_XELJANZ_tofacitinib_Prescriber's treatment maintenance checklist_L04AA29_EU/1/17/1178/001-015_20042023
RMM_XELJANZ_tofacitinib_Patient alert card_L04AA29_EU/1/17/1178/001-015_20042023
RMM_BAVENCIO_avelumab_Guide for patients_L01FF04_EU/1/17/1214/001_22052023
RMM_BAVENCIO_avelumab_Patient alert card_L01FF04_EU/1/17/1214/001_22052023
RMM_GENCEBOK_caffeine citrate_Alert card_N06BC01_EU/1/20/1465/001_25052023
RMM_MYRIN_thalidomide_Prescribers' guide and receipt form_L04AX02_26062023
RMM_MYRIN_thalidomide_Pharmacists' guide and receipt form_L04AX02_26062023
RMM_MYRIN_thalidomide_Informed consent form for women child bearing potential_L04AX02_26062023
RMM_MYRIN_thalidomide_Informed consent form for women non-child bearing potential_L04AX02_26062023
RMM_MYRIN_thalidomide_Informed consent form for males_L04AX02_26062023
RMM_OLUMIANT_baricitinib_Prescriber guide (atopic dermatitis)_L04AA37_EU/1/16/1170/001-016_06072023
RMM_OLUMIANT_baricitinib_Prescriber guide (rhuematoid arthritis)_L04AA37_EU/1/16/1170/001-016_06072023
RMM_OLUMIANT_baricitinib_Patient alert card_L04AA37_EU/1/16/1170/001-016_06072023
RMM_ENBREL_etanercept_Patient card_L04AB01_EU/1/99/126/002-032_10072023
RMM_PAMIDRO-CELL 3mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION_pamidronic acid_Patient card_M05BA03_AA565/92401_11072023
RMM_TECENTRIQ_atezolizumab_Patient card_L01XC32_EU/1/17/1220/001-2_02082023
RMM_HYRIMZOS_adalimumab_Adults' patient card_L04AB04_EU/1/18/1286/001-019_07082023
RMM_HYRIMZOS_adalimumab_Paediatrics' patient card_L04AB04_EU/1/18/1286/001-019_07082023
RMM_AMFEXA_dexamfetamine sulfate_Physicians' guide_N06BA02_AA1411/03301_07082023
RMM_AMFEXA_dexamfetamine sulfate_Physicians' checklist_N06BA02_AA1411/03301_07082023
RMM_AMFEXA_dexamfetamine sulfate_Considerations when ending treatment_N06BA02_AA1411/03301_07082023
RMM_AMFEXA_dexamfetamine sulfate_Chart for monitoring during the treatment_N06BA02_AA1411/03301_07082023
RMM_AMFEXA_dexamfetamine sulfate_Girls' chart for monitoring during the treatment_N06BA02_AA1411/03301_07082023
RMM_AMFEXA_dexamfetamine sulfate_Boys' chart for monitoring during the treatment_N06BA02_AA1411/03301_07082023
RMM_AMFEXA_dexamfetamine sulfate_Pharmacists' guide_N06BA02_AA1411/03301_07082023
RMM_AMFEXA_dexamfetamine sulfate_Caregivers' guide_N06BA02_AA1411/03301_07082023
RMM_LIBTAYO_cemiplimab_Patients' guide_L01XC33_EU/1/19/1376/001_16082023
RMM_LIBTAYO_cemiplimab_Patients' card_L01XC33_EU/1/19/1376/001_16082023
RMM_PADCEV_enfortumab vedotin_Patient card_L01FX13_EU/1/21/1615/001-2_14092023
RMM_MAYZENT_siponimod fumaric acid_Physician's checklist_L04AA42_EU/1/19/1414/001-008_13102023
RMM_MAYZENT_siponimod fumaric acid_Patient's guide_L04AA42_EU/1/19/1414/001-008_13102023
RMM_MAYZENT_siponimod fumaric acid_Gwida għall-pazjenti u kuraturi_L04AA42_EU/1/19/1414/001-008_13102023
RMM_MAYZENT_siponimod fumaric acid_Patient's card_L04AA42_EU/1/19/1414/001-008_13102023
RMM_MAYZENT_siponimod fumaric acid_Kartuna għall-pazjent_L04AA42_EU/1/19/1414/001-008_13102023
RMM_EXTRANEAL (ICODEXTRIN 7.5%) SOLUTION FOR PERITONEAL DIALYSIS_icodextrin_Glucose Monitor List_B05DA_MA1277/01101_13102023
RMM_CAPRELSA_vandetanib_Dosing and monitoring guide_L01XE_EU/1/11/749/001-2_16102023
RMM_CAPRELSA_vandetanib_Guide for healthcare professionals_L01XE_EU/1/11/749/001-2_16102023
RMM_CAPRELSA_vandetanib_Patient card_L01XE_EU/1/11/749/001-2_16102023
RMM_XOSPATA_gilteritinib fumarate_Guide for healthcare professionals_L01EX13_EU/1/19/1399/001_19102023
RMM_XOSPATA_gilteritinib fumarate_Patient card_L01EX13_EU/1/19/1399/001_19102023
RMM_IMNOVID_pomalidomide_Brochure for healthcare professionals_L04AX06_EU/1/13/850/001-008_19102023
RMM_IMNOVID_pomalidomide_Brochure for patients_L04AX06_EU/1/13/850/001-08_19102023
RMM_IMNOVID_pomalidomide_Patient card_L04AX06_EU/1/13/850/001-8_19102023
RMM_IMNOVID_pomalidomide_Product handling instructions_L04AX06_EU/1/13/850/001-8_19102023
RMM_IMNOVID_pomalidomide_Treatment initiation form for males_L04AX06_EU/1/13/850/001-8_19102023
RMM_IMNOVID_pomalidomide_Treatment initiation form for women of child-bearing potential_L04AX06_EU/1/13/850/001-8_19102023
RMM_IMNOVID_pomalidomide_Treatment initiation form for women not of child-bearing potential_L04AX06_EU/1/13/850/001-8_19102023
RMM_IMNOVID_pomalidomide_Prescriber acknowledgement form_L04AX06_EU/1/13/850/001-8_19102023
RMM_IMNOVID_pomalidomide_Risk awareness form_L04AX06_EU/1/13/850/001-8_19102023
RMM_APIXABAN MYLAN 2.5 MG, 5 MG_apixaban_Prescribers' guide_B01AF02_MA1270/02801-2_26102023
RMM_TOPAMAX 25MG, 50MG, 100MG, 200MG FILM-COATED TABLETS_topiramate_Healthcare professional guide_N03AX11_MA018/00301-4_TOPAMAX CAPSULES 15MG, 25MG, 50MG_topiramate_Healthcare professional guide_N03AX11_MA018/00305-7_23112023
RMM_TOPAMAX 25MG, 50MG, 100MG, 200MG FILM-COATED TABLETS_topiramate_Patient guide_N03AX11_MA018/00301-4_TOPAMAX CAPSULES 15MG, 25MG, 50MG_topiramate_Patient _guide_N03AX11_MA018/00305-7_23112023
RMM_JEXT 300 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED PEN_adrenaline_Prescriber checklist_C01CA24_AA770/08705_07122023
RMM_JEXT 300 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED PEN_adrenaline_Patient card_C01CA24_AA770/08705_07122023
RMM_VFEND_voriconazole_Patient card_J02AC03_EU/1/02/212/001-045_07122023
RMM_ELIQUIS_apixaban_Prescribers' guide_B01AF02_EU/1/11/691/001-015_07122023
RMM_MULTAQ_dronedrone_Prescriber guide_C01BD07_EU/1/09/591/001-4_21122023
RMM_OLUMIANT_baricitinib_Guide for healthcare professionals_L04AA37_EU/1/16/1170/001-019_21122023
RMM_TALVEY_talquetamab_Guide for healthcare professionals_L01FX29_EU/1/23/1748/001-2_21122023
RMM_TALVEY_talquetamab_Patient card_L01FX29_EU/1/23/1748/001-2_21122023
RMM_TIBSOVO 250MG FILM-COATED TABLETS_ivosidenib_Patient card_L01XX62_EU/1/23/1728/001_21122023
RMM_MYCOPHENOLATE MOFETIL 250MG CAPSULES_mycophenolate mofetil_Guide for healthcare professionals_L04AA06_27122023
RMM_MYCOPHENOLATE MOFETIL 250MG CAPSULES_mycophenolate mofetil_Guide for patients_L04AA06_27122023
RMM_REBLOZYL_luspatercept_Checklist for healthcare professionals_B03XA06_EU/1/20/1452/001-2_19012022
RMM_REBLOZYL_luspatercept_Patient card_B03AX06_EU/1/20/1452/001-2_19012022
RMM_ISOTRETINOIN CAPSULES 5MG, 20MG_isotretinoin_Prescribers' checklist_D10BA01_AA1282/00101-2_24012022
RMM_ISOTRETINOIN CAPSULES 5MG, 20MG_isotretinoin_Pharmacists' checklist_D10BA01_AA1282/00101-2_24012022
RMM_ISOTRETINOIN CAPSULES 5MG, 20MG_isotretinoin_Patient card_D10BA01_AA1282/00101-2_24012022
RMM_CIBINQO_abrocitinib_Prescriber guide_D11AH_EU/1/21/1593/001-015_14022022
RMM_CIBINQO_abrocitinib_Patient card_D11AH_EU/1/21/1593/001-015_14022022
RMM_MYRIN 50MG SUGAR COATED TABLETS_MYRIN 100MG SUGAR COATED TABLETS_thalidomide_Prescribers' guide_L04AX02_15022022
RMM_MYRIN 50MG SUGAR COATED TABLETS_MYRIN 100MG SUGAR COATED TABLETS_thalidomide_Pharmacists' guide_L04AX02_15022022
RMM_MYRIN 50MG SUGAR COATED TABLETS_ MYRIN 100MG SUGAR COATED TABLETS_thalidomide_Treatment initiation form for male patients_L04AX02_15022022
RMM_MYRIN 50MG SUGAR COATED TABLETS_MYRIN 100MG SUGAR COATED TABLETS_thalidomide_Treatment initiation form for women of non-childbearing potential_L04AX02_15022022
RMM_MYRIN 50MG SUGAR COATED TABLETS_MYRIN 100MG SUGAR COATED TABLETS_thalidomide_Treatment initiation form for women of child-bearing potential_L04AX01_15022022
RMM_MYRIN 50MG SUGAR COATED TABLETS_MYRIN 100MG SUGAR COATED TABLETS_thalidomide_Pregnancy initial reporting form_L04AX01_15022022
RMM_MYRIN 50MG SUGAR COATED TABLETS_MYRIN 100MG SUGAR COATED TABLETS_thalidomide_Pregnancy final reporting form_L04AX01_15022022
RMM_AMGEVITA_adalimumab_Adult patient reminder card_L04AB04_EU/1/16/1164/001-9_24022022
RMM_AMGEVITA_adalimumab_Paediatric patient reminder card_L04AB04_EU/1/16/1164/001-9_24022022
RMM_EYLEA_aflibercept_Prescriber's guide_S01LA05_EU/1/12/797/001-2_24022022
RMM_BOSENTAN AUROBINDO 62.5MG FILM-COATED TABLET_BOSENTAN AUROBINDO 125MG FILM-COATED TABLET_bosentan_C02KX01__Patient alert card_MA807/09201-2_24022022
RMM_PRADAXA_dabigatran etexilate_Prescribers' guide for paediatric use_B01AE07_EU/1/08/442/001-031_03032021
RMM_EMTRICITABINE/TENOFOVIR DISOPROXIL MYLAN_emtricitabine/tenofovir disoproxil maleate_HIV Paediatric Renal educational guide for prescribers_J05AR03_EU/1/16/1133/001-6_03032022
RMM_EMTRICITABINE/TENOFOVIR DISOPROXIL MYLAN_emtricitabine/tenofovir disoproxil maleate_PrEP educational guide for prescribers_J05AR03_EU/1/16/1133/001-6_03032022
RMM_EMTRICITABINE/TENOFOVIR_DISOPROXIL_MYLAN_emtricitabine/tenofovir_disoproxil maleate_PrEP educational guide for patient_J05AR03_EU/1/16/1133/001-6_03032022
RMM_EMTRICITABINE/TENOFOVIR DISOPROXIL_MYLAN_emtricitabine/tenofovir_disoproxil_maleate_PrEP checklist for prescribers_J05AR03_EU/1/16/1133/001-6_03032022
RMM_EMTRICITABINE/TENOFOVIR DISOPROXIL_MYLAN_emtricitabine/tenofovir_disoproxil_maleate_PrEP Patient reminder card_J05AR03_EU/1/16/1133/001-6_03032022
RMM_PIQRAY_alpelisib_Guide for healthcare professionals_L01XX65_EU/1/20/1455/001-9_17032022
RMM_RUBIFEN 10MG TABLET_methylphenidate_Physician's guide_N06BA04_21032022
RMM_RUBIFEN 10MG TABLET_methylphenidate_Chart for ongoing monitoring during methyphenidate treatment_N06BA04_21032022
RMM_RUBIFEN 10MG TABLET_methylphenidate_Checklist 1_Methylphenidate checklist before prescribing_N06BA04_21032022
RMM_RUBIFEN 10MG TABLET_methylphenidate_Checklist 2_Methylphenidate checklist for monitoring of ongoing therapy_N06BA04_21032022
RMM_RIVAROXABAN PHAROS 2.5MG, 10MG, 15MG, 20MG FILM-COATED TABLETS_rivaroxaban_Prescribers' guide_B01AF01_MMA918/01501-5_21032022
RMM_RIVAROXABAN PHAROS 2.5MG, 10MG, 15MG, 20MG FILM-COATED TABLETS_rivaroxaban_Patient alert card_B01AF01_MA918/01501-5_21032022
RMM_XELJANZ_tofacitinib_Prescriber's guide_L04AA29_EU/1/17/1178/001/015_22032022
RMM_XELJANZ_tofacitinib_Prescriber treatment initiation checklist_L04AA29_EU/1/17/1178/001-015_22032022
RMM_XELJANZ_tofacitinib_Prescriber treatment_maintenance checklist_L04AA29_EU/1/17/1178/001-015_22032022
RMM_XELJANZ_tofacitinib_Patient alert card_L04AA29_EU/1/17/1178/001-015_22032022
RMM_BAVENCIO_avelumab_Guide for patients_L01XC31_EU/1/17/1214/001_24032022
RMM_BAVENCIO_avelumab_Patient alert card_L01XC31_EU/1/17/1214/001_24032022
RMM_MAVENCLAD_cladribine_Prescribers' guide_L04AA40_EU/1/17/1212/001-6_14042022
RMM_MAVENCLAD_cladribine_Guide for patients_L04AA40_EU/1/17/1212/001-6_14042022
RMM_BEOVU_brolucizumab_Guide for patients_S01LA06_EU/1/19/1417/001-2_12052022
RMM_DARZALEX_daratumumab_Guide for healthcare professionals_L01XC24_EU/1/16/1101/004_19052022
RMM_DARZALEX_daratumumab_Guide for blood bank_L01XC24_EU/1/16/1101/004_19052022
RMM_DARZALEX_daratumumab_Patient card_L01XC24_EU/1/16/1101/004_19052022
RMM_OPSUMIT_macitentan_Patient card_C02KX04_EU/1/13/893/001-2_03062022
RMM_TRUXIMA_rituximab_Guide for healthcare professionals_L01FA01_EU/1/16/1167/001-2_10062022
RMM_TRUXIMA_rituximab_Guide for patients_L01FA01_EU/1/16/1167/001-2_10062022
RMM_ISOTRETINOIN 10mg, 20mg SOFT CAPSULES_isotretinoin_Physician's checklist_D10BA01_AA1122/02901-2_24062022
RMM_ISOTRETINOIN 10mg, 20mg SOFT CAPSULES_isotretinoin_Pharmacist's checklist_D10BA01_AA1122/02901-2_24062022
RMM_ISOTRETINOIN 10mg, 20mg SOFT CAPSULES_isotretinoin_Patient reminder card_D10BA01-AA1122/02901-2_24062022
RMM_VORICONAZOLE ZENTIVA 200MG FILM-COATED TABLETS_voriconazole_Question and answer guide for healthcare professionals_J02AC03_AA565/87001_24062022
RMM_VORICONAZOLE ZENTIVA 200MG FILM-COATED TABLETS_voriconazole_Checklist for healthcare professionals_J02AC03_AA565/87001_24062022
RMM_VORICONAZOLE ZENTIVA 200MG FILM-COATED TABLETS_voriconazole_Patient alert card_J02AC03_AA565/87001_23062022
RMM_ROACTEMRA_tocilizumab_Guide for healthcare professionals_L04AC07_EU/1/08/492/001-010_30062022
RMM_ROACTEMRA_tocilizumab_Dosing guide_L04AC07_EU/1/08/492/001-010_30062022
RMM_ROACTEMRA_tocilizumab_Guide for patients_L04AC07_EU/1/08/492/001-010_30062022
RMM_ROACTEMRA_tocilizumab_Patient alert card_L04AC07_EU/1/08/492/001-010_30062022
RMM_TECENTRIQ_atezolizumab_Patient alert card_L01XC32_EU/1/17/1220/001-2_18072022
RMM_ERELZI_etanercept_Patient card_L04AB01_EU/1/17/1195/001-014_01082022
RMM_ERELZI_etanercept_Kard tal-pazjent_L04AB01_EU/1/17/1195/001-014_01082022
RMM_LIBTAYO_cemiplimab_Guide for patients_L01XC33_EU/1/19/1376/001_01082022
RMM_LIBTAYO_cemiplimab_Patient card_L01XC33_EU/1/19/1376/001_01082022
RMM_YASMIN 0.03MG/3MG FILM-COATED TABLET_ethinylestradiol_drospirenone_Prescriber's checklist_G03AA12_PI908/16401B_01082022
RMM_YASMIN 0.03MG/3MG FILM-COATED TABLET_ethinlyestradiol_drospirenone_Patient's card_G03AA12_PI908/16401B-01082022
RMM_PONVORY_ponesimod_Prescribers' checklist_L04AA50_EU/1/21/1550/001-3_04082022
RMM_PONVORY_ponesimod_Patients' guide_L04AA50_EU/1/21/1550/001-3_04082022
RMM_PONVORY_ponesimod_Pregnancy reminder card_L04AA50_EU/1/21/1550/001-3_04082022
RMM_REMSIMA_infliximab_Patient card_L04AB02_EU/1/13/853/001-017_05092022
RMM_OLUMIANT_baricitinib_Guide for healthcare professionals_L04AA37_EU/1/16/1170/001-016_28092022
RMM_TRIUMEQ_dolutegravir sodium_lamivudine_abacavir_Patient card_J05AR13_EU/1/14/940/001-2_28092022
RMM_GILENYA_fingolimod hydrochloride_Physician's checklist_L04AA27_EU/1/11/677/001-8_10102022
RMM_MYFORTIC 180MG, 360MG GASTRO-RESISTANT TABLETS_mycophenolic acid_Guide for healthcare professionals_L04AA06_MA1249/00301-2_10102022
RMM_PIQRAY_alpelisib_Guide for healthcare professionals_L01XE_EU/1/20/1455/001-9_10102022
RMM_METHYLPHENIDATE HYDROCHLORIDE 36MG PROLONGED RELEASE TABLETS_methylphenidate_Guide for healthcare professionals_N06BA04_13102022
RMM_METHYLPHENIDATE HYDROCHLORIDE 36MG PROLONGED RELEASE TABLETS_methylphenidate_Checklist before prescribing_N06BA04_13102022
RMM_METHYLPHENIDATE HYDROCHLORIDE 36MG PROLONGED RELEASE TABLETS_methylphenidate_Checklist for monitoring of ongoing therapy_N06BA04_13102022
RMM_METHYLPHENIDATE HYDROCHLORIDE 36MG PROLONGED RELEASE TABLETS_methylphenidate_Chart for ongoing monitoring during methylphenidate treatment_N06BA04_13102022
RMM_TECVAYLI_teclistamab_Patient card_EU/1/22/1675/001-2_17102022
RMM_MAYZENT_siponimod fumaric acid_Physician's checklist_L04AA42_EU/1/19/1414/001-8_17102022
RMM_MAYZENT_siponimod fumaric acid_Patient's and caregiver's guide_L04AA42_EU/1/19/1414/001-8_17102022
RMM_MAYZENT_siponimod fumaric acid_Gwida għall-pazjenti u kuraturi_L04AA42_EU/1/19/1414/001-8_17102022
RMM_MAYZENT_siponimod fumaric acid_Patient's card_L04AA42_EU/1/19/1414/001-8_17102022
RMM_MAYZENT_siponimod fumaric acid_Kartuna tal-pazjent_L04AA42_EU/1/19/1414/001-8_17102022
RMM_EPILIM_valproate sodium_Prescriber's guide_N03AG01_MA1359/01901-4_27102022
RMM_EPILIM_valproate sodium_Guide for patients_N03AG01_MA1359/01901-4_27102022
RMM_EPILIM_valproate sodium_Patient card_N03AG01_MA1359/01901-4_27102022
RMM_EPILIM_valproate sodium_Annual risk acknowledgment form_N03AG01_MA1359/01901-4_27102022
RMM_LEMTRADA_alemtuzumab_Guide for healthcare professionals_L04AA34_EU/1/13/869/001_14112022
RMM_LEMTRADA_alemtuzumab_Checklist for healthcare professionals_L04AA34_EU/1/13/869/001_14112022
RMM_LEMTRADA_alemtuzumab_Patient guide_L04AA34_EU/1/13/869/001_14112022
RMM_KEYTRUDA_pembrolizumab_Guide for patients_L01FF02_EU/1/15/1024/002_28112022
RMM_KEYTRUDA_pembrolizumab_Patient alert card_L01FF02_EU/1/15/1024/002_28112022
RMM_REMICADE_infliximab_Patient reminder card_L04AB02_EU/1/99/116/001-5_28112022
RMM_MIRENA 52MG INTRAUTERINE DELIVERY SYSTEM_levonorgestrel_Guide for healthcare professionals_G02BA03_MA639/02201_JAYDESS 13.5MG INTRAUTERINE DELIVERY SYSTEM_levonorgestrel_Guide for healthcare professionals_G02BA03_MA639/02101_02122022
RMM_XALKORI_crizotinib_Patient information guide including a patient alert card_L01ED01_EU/1/12/793/001-4_05122022
RMM_PRADAXA_dabigatran etexilate mesilate_Prescribers' guide_B01AE07_EU/1/08/442/001-031_05122022
RMM_EXTRANEAL (ICODEXTRIN 7.5%) SOLUTION FOR PERITONEAL DIALYSIS_icodextrin_Glucose monitor list_B05DA_MA1277/01101_07122022
RMM_HULIO_adalimumab_Patient card for adults_L04AB04_EU/1/18/1319/001-070_07122022
RMM_HULIO_adalimumab_Patient card for children_L04AB04_EU/1/18/1319/001-070_07122022
RMM_EXJADE_deferasirox_Guide for healthcare professionals_V03AC03_EU/1/06/356/011-022_09122022
RMM_EXJADE_deferasirox_Physicians' reference checklist_V03AC03_EU/1/06/356/011-022_09122022
RMM_EXJADE_deferasirox_Guide for patients_V03AC03_EU/1/06/356/011-022_09122022
RMM_EXJADE_deferasirox_Gwida għall-pazjenti_V03AC03_EU/1/06/356/011-022_09122022
RMM_OPDUALAG_nivolumab_relatlimab_Patient card_L01XY03_EU/1/22/1679/001_15122022
RMM_ENHERTU_trastuzumab deruxtecan_Health care professional guide for prevention of product confusion medication errors_L0FD04_EU/1/20/1508/001_16122022
RMM_ENHERTU_trastuzumab deruxtecan_Health care professional guide: important safety information on ILD/pneumonitis with treatment of Enhertu_L0FD04_EU/1/20/1508/001_16122022
RMM_ENHERTU_trastuzumab deruxtecan_Patient card_L0FD04_EU/1/20/1508/001_16122022
RMM_DEFERASIROX BETA 180MG FILM-COATED TABLETS_deferasirox_Guide for healthcare professionals_V03AC03_AA1411/01601_19122022
RMM_DEFERASIROX BETA 180MG FILM-COATED TABLETS_deferasirox_Guide for patients_V03AC03_AA1411/01601_19122022
RMM_DEFERASIROX BETA 180MG FILM-COATED TABLETS_deferasirox_Physician's reference checklist_V03AC03_AA1411/01601_19122022
RMM_A-CNOTREN 20mg SOFT CAPSULES_isotretinoin_Physicians checklist_D10BA01_AA908/20201_11012021
RMM_A-CNOTREN 20mg SOFT CAPSULES_isotretinoin_Pharmacist checklist_D10BA01_AA908/20201_11012021
RMM_A-CNOTREN 20mg SOFT CAPSULES_isotretinoin_Patient reminder card_D10BA01_AA908/20201_11012021
RMM_RIVAROLTO 10MG FILM-COATED TABLETS_rivaroxaban_Prescriber guide_B01AF01_MA982/01702_11012021
RMM_RIVAROLTO 10MG FILM-COATED TABLETS_rivaroxaban_Patient alert card_B01AF01_MA982/01702_11012021
RMM_EYLEA_aflibercept_Prescriber guide_S01LA05_EU/1/12/797/001-2_15012021
RMM_LIBTAYO_cemiplimab_Patient Guide_L01XC33_EU/1/19/1376/001_18012021
RMM_LIBTAYO_cemiplimab_Patient alert card_L01XC33_EU/1/19/1376/001_18012021
RMM_ESCAPELLE 1500 MICROGRAMS TABLET_levonorgestrel_Brochure for healthcare professionals_G03AD01_MA1031/00301_22012021
RMM_ESCAPELLE 1500 MICROGRAMS TABLET_levonorgestrel_Brochure for patients_G03AD01_MA1031/00201_22012021
RMM_REVLIMID_lenalidomide_Guide for healthcare professionals_L04AX04_EU/1/07/391/001-014_03032021
RMM_REVLIMID_lenalidomide_Guide for male patients_L04AX04_EU/1/07/391/001-014_03032021
RMM_REVLIMID_lenalidomide_Guide for women of child-bearing potential_L04AX04_EU/1/07/391/001-014_03032021
RMM_REVLIMID_lenalidomide_Guide for women of not child-bearing potentila _L04AX04_EU/1/07/391/001-014_03032021
RMM_REVLIMID_lenalidomide_Patient card_L04AX04_EU/1/07/391/001-014_03032021
RMM_REVLIMID_lenalidomide_Kard tal-pazjent_L04AX04_EU/1/07/391/001-014_03032021
RMM_REVLIMID_lenalidomide_Treatment initiation form for male patients_L04AX04_EU/1/07/391/001-014_03032021
RMM_REVLIMID_lenalidomide_Treatment initiation form for women of child-bearing potential_L04AX04_EU/1/07/391/001-014_03032021
RMM_REVLIMID_lenalidomide_Treatment initiation form for women of not child-bearing potential_L0AX04_EU/1/07/391/001-014-03032021
RMM_EXJADE_deferasirox_Physician's Checklist_V03AC03_EU/1/06/356/001-022_26032021
RMM_REMSIMA_infliximab_Patient reminder card_L04AB02_EU/1/13/853/001-017_30032021
RMM_SPRAVATO_esketamine hydrochloride_Guide for healthcare professionals_N06AX27_EU/1/19/1410/001-5_16042021
RMM_SPRAVATO_esketamine hydrochloride_Checklist for healthcare professionals_N06AX27_EU/1/19/1410/001-5_16042021
RMM_SPRAVATO_esketamine hydrochloride_Guide for patients_N06AX27_EU/1/19/1410/001-5_16042021
RMM_RUXIENCE_rituximab_Guide for healthcare professionals_L01XC02_EU/1/20/1431/001-2_19042021
RMM_RUXIENCE_rituximab_Guide for patients_L01XC02_EU/1/20/1431/001-2_19042021
RMM_RUXIENCE_rituximab_Patient alert card_L01XC02_EU/1/20/1431/001-2_19042021
RMM_INOMAX_nitric oxide_Guide for healthcare professionals_R07AX_EU/1/01/194/001-4_23042021
RMM_GILENYA_fingolimod hydrochloride_Physician Checklist_L04AA27_EU/1/11/677/001-8_23042021
RMM_GILENYA_fingolimod hydrochloride_Patient guide_L04AA27_EU/1/11/677/001-8_23042021
RMM_GILENYA_fingolimod hydrochloride_Gwida għall-pazjent_L04AA27_EU/1/11/677/001-8_23042021
RMM_GILENYA_fingolimod hydrochloride_Parents and caregivers guide_L04AA27_EU/1/11/677/001-8_23042021
RMM_GILENYA_fingolimod hydrochloride_Gwida għall-ġenituri u l-kuraturi_L04AA27_EU/1/11/677/001-8_23042021
RMM_GILENYA_fingolimod hydrochloride_Pregnancy specific patient reminder card_L04AA27_EU/1/11/677/001-8_23042021
RMM_GILENYA_fingolimod hydrochloride_Kartuna li tfakkar lill-pazjenti specifikament dwar it-tqala_L04AA27_EU/1/11/677/001-8_23042021
RMM_MAYZENT_siponimod fumaric acid_Checklist for healthcare professional_L04AA42_EU/1/19/1414/001-6_27042021
RMM_MAYZENT_siponimod fumaric acid_Patient and caregiver guide_L04AA42_EU/1/19/1414/001-6_27042021
RMM_MAYZENT_siponimod fumaric acid_Gwida għall-kuratur u pazjent_L04AA42_EU/1/19/1414/001-6_27042021
RMM_MAYZENT_siponimod fumaric acid_Pregnancy reminder card_L04AA42_EU/1/19/1414/001-6_27042021
RMM_MAYZENT_siponimod fumaric acid_Kartuna ta' tfakkir dwar tqala għan-nisa li jistgħu joħorgu tqal_L04AA42_EU/1/19/1414/001-6_27042021
RMM_KISQALI_ribociclib succinate_Patient guide_L01XE42_EU/1/17/1221/001-012_27042021
RMM_KISQALI_ribociclib succinate_Patient guide_L01XE42_EU/1/17/1221/001-012_07052021
RMM_HUMIRA_adalimumab_Adult patient reminder card_L04AB04_EU/1/03/256/001-027_10052021
RMM_HUMIRA_adalimumab_Pediatric patient reminder card_L04AB04_EU/1/03/256/001-027_10052021
RMM_EPILIM_valproate sodium_Annual risk acknowledgement form_N03AG01_MA1359/01901-4_11052021
RMM_EPILIM_valproate sodium_Patient guide_N03AG01_MA1358/01901-4_11052021
RMM_EPLIM_valproate sodium_Patient card_N03AG01_MA1358/01901-4_11052021
RMM_XARELTO_rivaroxaban_Prescriber guide_B01AF01_EU/1/08/472/001-051_11052021
RMM_XARELTO_rivaroxaban_Patient alert card_B01AF01_EU/1/08/472/001-051_11052021
RMM_MIRENA 52mg INTRAUTERINE DELIVERY SYSTEM_Guide for healthcare professionals_G02BA03_MA639/02201_JAYDESS 13.5mg INTRAUTERINE DELIVERY SYSTEM_Guide for healthcare professionals_G02BA03_MA639/02101_13052021
RMM_CONCERTA_methylphenidate hydrochloride_Lista ta' kontroll 1: Lista ta' kontroll għal methylphenidate (MPH) qabel il-preskrizzjoni_N06BA04_MA018/02601-4_15092021
RMM_CONCERTA_methylphenidate hydrochloride_Lista ta' kontroll 2: Lista ta' kontroll għal methylphenidate (MPH) għall-monitoragg ta' terapija kontinwu_N06BA04_MA018/02601-4_15092021
RMM_CONCERTA_methylphenidate hydrochloride_Ċart għal-monitoraġġ kontinwu_N06BA04_MA018/02601-4_15092021
RMM_VYNDAQEL_tafamidis_Guide for healthcare professionals_N07XX08_EU/1/11/717/001-4_24052021
RMM_TECENTRIQ_atezolizumab_Patient alert card_L01XC_EU/1/17/1220/001-2_26052021
RMM_LUCENTIS_ranibizumab_Patient guide for the treatment of neovascular (wet) age-related macular degeneration (wAMD)_S01LA04_EU/1/06/374/002-4_02062021
RMM_LUCENTIS_ranibizumab_Patient guide for the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central /RVO)_S01LA04_EU/1/06/374/002-4_02062021
RMM_LUCENTIS_ranibizumab_Patient guide for the proliferative diabetic retinopathy (PDR) and/or visual impairment due to diabetic macular oedema (DME)_S01LA04_EU/1/06/374/002-4_02062021
RMM_LUCENTIS_ranibizumab_Patient guide for the visual impairment due to diabetic macular oedema (DME)_S01LA04_EU/1/06/374/002-4_02062021
RMM_LUCENTIS_ranibizumab_Patient guide for the visual impairment due to choroidal neovascularization (CNV)_S01LA04_EU/1/1/06/374/002-4_02062021
RMM_NEOTIGASON_acitretin_Physician checklist_D05BB02_AA565/80401_10062021
RMM_NEOTIGASON_acitretin_Patient reminder card_D05BB02_AA565/80401_10062021
RMM_TYSABRI_natalizumab_Physician information and management guidelines_L04AA23_EU/1/06/346/001-2_21062021
RMM_ELIQUIS_apixaban_Prescriber guide_B01AF02_EU/1/11/691/001-015_15072021
RMM_AMFEXA 5MG TABLETS_dexamfetamine sulfate_Male growth monitoring chart_N06BA02_AA1369/01501_5082021
RMM_AMFEXA 5MG TABLETS_dexamfetamine sulfate_Female growth monitoring chart_N06BA02_AA1369/01501_5082021
RMM_ZOMETA_zoledronic acid_Patient card_M05BA08_EU/1/01/176/001-9_12082021
RMM_PIQRAY_alpelisib_Guide for healthcare professionals_L01XX65_EU/1/20/1455/001-9_13082021
RMM_BAVENCIO_avelumab_Guide for patients_L01XC31_EU/1/17/1214/001_06092021
RMM_BAVENCIO_avelumab_Patient alert card_L01XC31_EU/1/17/1214/001_060921021
RMM_IMNOVID_pomalidomide_Pregnancy form_L04AX06_EU/1/13/850/001-8_06092021
RMM_VENCLYXTO_venetoclax_Patient card_L01XX52_EU/1/16/1138/001-7_14092021
RMM_ZOLEDRONIC ACID TILLOMED 4MG/5ML CONCENTRATE FOR SOLUTION FOR INFUSION_zoledronic acid_Patient reminder card_M05BA08_AA565/81001_27092021
RMM_ENSPRYNG_satralizumab_Patient alert card_L04AC_EU/1/21/1559/001-2_05102021
RMM_RIVAROXABAN SANDOZ 10MG FILM-COATED TABLETS_rivaroxaban_Prescriber's guide_B01AF01_MA685/02901-3_07102021_RIVAROXABAN SANDOZ 15MG_rivaroxaban_Prescriber's guide_B01AF01_MA685/02901-3_RIVAROXABAN SANDOZ 20MG_rivaroxaban_Prescriber's guide_B01AF01_MA685/02901-3_07102021
RMM_RIVAROXABAN SANDOZ 10MG FILM-COATED TABLETS_rivaroxaban_Patient alert card_B01AF01_MA685/02901-3_07102021_RIVAROXABAN SANDOZ 15MG FILM-COATED TABLETS_rivaroxaban_Patient alert card_B01AF01_MA685/02901-3_RMM_RIVAROXABAN SANDOZ 20MG FILM-COATED TABLETS_rivaroxaban_Patient alert card_B01AF01_MA685/02901-3_07102021
RMM_DARZALEX_daratumumab_Guide for healthcare professionals_L01XC24_EU/1/16/1101/001-3_07102021
RMM_DARZALEX_daratumumab_Patient alert card_L01XC24_EU/1/16/1101/001-3_07102021
RMM_DARZALEX_daratumumab_Guide for blood bank_L01XC24_EU/1/16/1101/001-3_07102021
RMM_SPRAVATO_esketamine hydrochloride_Guide for healthcare professionals_N06AX27_EU/1/19/1410/001-5_07102021
RMM_SPRAVATO_esketamine hydrochloride_Checklist for healthcare professionals_N06AX27_EU/1/19/1410/001-5_07102021
RMM_SPRAVATO_esketamine hydrochloride_Guide for patients_N06AX27_EU/1/19/1410/001-5_07102021
RMM_AUBAGIO_teriflunomide_Guide for healthcare professionals_L04AA31_EU/1/13/838/001-5_28102021
RMM_AUBAGIO_teriflunomide_Patient card_L04AA31_EU/1/13/838/001-5_28102021
RMM_MULTAQ_dronedrone_Guide for prescribers_C01BD07_EU/1/09/591/001-4_22112021
RMM_OLUMIANT_baricitinib_Guide for prescribers_L04AA37_EU/1/16/1170/001-016_23112021
RMM_OLUMIANT_baricitinib_Patient alert card_L04AA37_EU/1/16/1170/001-016_23112021
RMM_OLUMIANT_baricitinib_Guide for prescribers_L04AA37_EU/1/16/1170/001-016_02122021
RMM_OLUMIANT_baricitinib_Patient alert card_L04AA37_EU/1/16/1170/001-016_02122021
RMM_RAXIVANOL 10MG, 15MG, 20MG TABLETS_rivaroxaban_Prescriber guide_B01AF01_MA240/03101-3_14122021
RMM_RAXIVANOL 10MG, 15MG, 20MG TABLETS_rivaroxaban_Patient alert card_B01AF01_MA240/03101-3_14122021
RMM_XARELTO_rivaroxaban_Prescriber guide_B01AF01_EU/1/08/472/001-051_16122021
RMM_KADCYLA_trastuxumab emtansine_Guide for healthcare professionals_L01XC14_EU/1/13/885/001-2_20122021
RMM_EXTRANEAL (ICODEXTRIN 7.5%) SOLUTION FOR PERITONIAL DIALYSIS_calcium chloride_icodextrin_magnesium chloride_sodium chloride_ sodium lactate_Glucose monitor list_B05DA_MA1277/01101_23122021
RMM_FORXIGA_dapagliflozin propanediol monohydrate_Guide for health care professionals_A10BK01_EU/1/12/795/001-010_09012020
RMM_ROACTEMRA_tocilizumab_Dosing guide_L04AC07_EU/1/08/492/001-010_15012020
RMM_RIVAROXABAN SANDOZ 10mg FILM-COATED TABLETS_rivaroxaban_Prescriber's guide_B01AF01_MA685/02901_20012020
RMM_RIVAROXABAN SANDOZ 10mg FILM-COATED TABLETS_rivaroxaban_Patient alert card_B01AF01_MA685/02901_20012020
RMM_IMNOVID_pomalidomide_Brochure for healthcare professionals_L04AX06_EU/1/13/850/001-8_22012020
RMM_IMNOVID_pomalidomide_Brochures for patients_L04AX06_EU/1/13/850/001-8_22012020
RMM_IMNOVID_pomalidomide_Patient card_L04AX06_EU/1/13/850/001-8_22012020
RMM_IMNOVID_pomalidomide_Treatment initiation form for women patients of childbearing potential_L04AX06_EU/1/13/850/001-8_22012020
RMM_IMNOVID_pomalidomide_Treatment initiation form for women patients not of childbearing potential_L04AX06_EU/1/13/850/001-8_22012020
RMM_IMNOVID_pomalidomide_Treatment initiation form for male patients_L04AX06_EU/1/13/850/001-8_22012020
RMM_XARELTO_rivaroxaban_Prescriber guide_B01AF01_EU/1/08/472/001-049_27012020
RMM_TYSABRI_natalizumab_Physician information and management guidelines for patients with multiple sclerosis receiving Tysabri therapy_L04AA23_EU/1/06/346/001_28012020
RMM_METHOTREXATE 2.5mg FILM-COATED TABLETS_methotrexate_Guide for healthcare professionals_L01BA01_AA084/05701_03022020
RMM_PRADAXA_dabigatran etexilate_Prescriber guide for primary prevention of venous thromboembolic events (VTE) following elective total hip or kneww replacement surgery_B01AE07_EU/1/08/442/001-019_04022020
RMM_PRADAXA_dabigatran etexilate_Prescriber guide_B01AE07_EU/1/08/442/001-019_04022020
RMM_EPILIM_valproate sodium_Booklet for healthcare professionals_N03AG01_AA082/04312-3_20022020
RMM_EPILIM_valproate sodium_Acknowledgement form_N03AG01_AA082/04312-3_20022020
RMM_KADCYLA_trastuzumab emtansine_Brochure for healthcare professionals_L01XC14_EU/1/13/885/001-2_04032020
RMM_XELJANZ_tofacitinib_Brochure for prescriber_L04AA29_EU/1/17/1178/001-014_24032020
RMM_XELJANZ_tofacitinib_Patient alert card_L04AA29_EU/1/17/1178/001-014_24032020
RMM_XELJANZ_tofacitinib_Initiation checklist_L04AA29_EU/1/17/1178/001-014_24032020
RMM_XELJANZ_tofacitinib_Maintenance checklist_L04AA29_EU/1/17/1178/001-014_24032020
RMM_BEOVU_brolucizumab_Guide for patients_S01LA06_EU/1/19/1417/001-2_09042020
RMM_PALYNZIQ_pegvaliase_Important information for healthcare professionals_A16AB19_EU/1/19/1362/001-4_13042020
RMM_PALYNZIQ_pegvaliase_Important information for patients and trained observers_A16AB19_EU/1/19/1362/001-4_13042020
RMM_PALYNZIQ_pegvaliase_Patient alert card_A16AB19_EU/1/19/1362/001-4_13042020
RMM_REVLIMID_lenalidomide_Brochure for healthcare professionals_L04AX04_EU/1/07/391/001-014_30042020
RMM_REVLIMID_lenalidomide_Brochure for male patients_L04AX04_EU/1/07/391/001-014_30042020
RMM_REVLIMID_lenalidomide_Brochure for WCBP_L04AX04_EU/1/07/391/001-014_30042020
RMM_REVLIMID_lenalidomide_Brochure for WNCBP_L04AX04_EU/1/07/391/001-014_30032020
RMM_MAYZENT_siponimod_Checklist for healthcare professionals_L04AA42_EU/1/19/1414/001-6_04052020
RMM_MAYZENT_siponimod_Information for patients_L04AA42_EU/1/19/1414/001-6_04052020
RMM_MAYZENT_siponimod_Karta tal-pazjent_L04AA42_EU/1/19/1414/001-6_04052020
RMM_MAYZENT_siponimod_Patient and caregiver guide_L04AA42_EU/1/19/1414/001-6_04052020
RMM_MAYZENT_siponimod_Gwida għall-pazjenti u l-kuraturi_L04AA42_EU/1/19/1414/001-6_04052020
RMM_ERELZI_etanercept_A demostration kit for healthcare providers_L04AB01_EU/1/17/1195/001-014_07052020
RMM_ERELZI_etanercept_Patient alert card_L04AB01_EU/1/17/1195/001-014_07052020
RMM_ERELZI_etanercept_Kartuna ta' twissija għall-pazjent_L04AB01_EU/1/17/1195/001-014_07052020
RMM_AUBAGIO_teriflunomide_Guide for healthcare professionals_L04AA31_EU/1/13/838/001-5_19052020
RMM_AUBAGIO_teriflunomide_Patient card_L04AA31_EU/1/13/838/001-5_19052020
RMM_MIRENA 52mg INTRAUTERINE DELIVERY SYSTEM_levonorgestrel_Brochure for healthcare professionals_G02BA03_MA639/02201_20052020
RMM_ELIQUIS_apixaban_Prescriber guide_B01AF02_EU/1/11/691/001-015_01062020
RMM_ELIQUIS_apixaban_Patient alert card_B01AF02_EU/1/11/691/001-015_01062020
RMM_ELIQUIS_apixaban_Kartuna għal-pazjent_B01AF02_EU/1/11/691/001-015_01062020
RMM_OPDIVO_nivolumab_Patient alert card_L01XC17_EU/1/15/1014/001-3_16062020
RMM_MABTHERA_rituximab_Brochure for healthcare professionals_L01XC02_EU/1/08/067/001-2_26062020
RMM_MABTHERA_rituximab_Brochure for patient_L01XC02_EU/1/08/067/001-2_26062020
RMM_LEDAGA_chlormethine_Patient and caregiver instructions_L01AA05_EU/1/16/1171/001_17072020
RMM_LEDAGA_chlormethine_Sticker_L01AA05_EU/1/16/1171/001_17072020
RMM_XALKORI_crizotinib_Booklet for patients_L01XE16_EU/1/12/793/001-4_22072020
RMM_ABACAVIR/LAMIVUDINE Dr. REDDY'S 600mg/300mg FILM-COATED TABLETS_abacavir_lamivudine_Patient alert card_J05AR02_AA565/70901_27072020
RMM_ABACAVIR/LAMIVUDINE Dr. REDDY's 600mg/300mg FILM-COATED TABLETS_abacavir_lamivudine_Key risk minimisation points_J05AR02_AA565/70901_27072020
RMM_VALDOXAN_agomelatine_Information for healthcare professionals_N06AX22_EU/1/08/499/002-8_29072020
RMM_VALDOXAN_agomelatine_Guide for patients_N06AX22_EU/1/08/499/002-8_29072020
RMM_PARACETAMOL KABI 10mg/ml SOLUTION FOR INFUSION_paracetamol_Guide for healthcare professionals_AA1123/00701_29072020
RMM_PARACETAMOL KABI 10mg/ml SOLUTION FOR INFUSION_paracetamol_Poster_AA1123/00701_29072020
RMM_IMNOVID_pomalidomide_Brochure for healthcare professionals_L04AX06_EU/1/13/850/001-5_10082020
RMM_IMNOVID_pomalidomide_Brochures for patients_L04AX06_EU/1/13/850/001-5_10082020
RMM_ZOMETA_zoledronic acid_Patient card_M05BA08_EU/1/01/176/001-9_12082020
RMM_YERVOY_ipilimumab_Patient information guide_L01XC11_EU/1/11/698/001-2_12082020
RMM_YERVOY_ipilimumab_Patient alert card_L01XC11_EU/1/11/698/001-2-12082020
RMM_ADELE 0.015mg/0.03mg TABLET_desogestrel_ethinylestradiol_Checklist for prescribers_G03AA09_AA1006/01001_VREYA 0.035mg/2mg COATED TABLETS_ethinylestradiol_cyproterone acetate_Checklist for prescribers_G03HB01_SUNYA 0.020mg/0.075mg COATED TABLETS_ethinylestradiol_gestodene_Checklist for prescribers_G03AA10_AA1006/00701_NELYA 0.06mg/0.015mg FILM-COATED TABLETS_gestodene_ethinylestradiol_Checklist for prescribers_G03AA10_AA1006/00801_KATYA 0.030mg/0.075mg COATED TABLETS_ethinylestradiol_gestodene_Checklist for prescribers_G03AA10_AA1006/00901_17082020
RMM_ADELE 0.015mg/0.03mg TABLET_desogestrel_ethinylestradiol_Patient sheet_G03AA09_AA1006/01001_VREYA 0.035mg/2mg COATED TABLETS_ethinylestradiol_cyproterone acetate_Patient sheet_G03HB01_SUNYA 0.020mg/0.075mg COATED TABLETS_ethinylestradiol_gestodene_Patient sheet_G03AA10_AA1006/00701_NELYA TABLETS_ethinylestradiol_gestodene_Patient sheet_G03AA10_AA1006/00901_KATYA 0.030mg/0.075mg COATED TABLETS_ethinylestradiol_gestodene_G03AA10_Patient sheet_AA1006/00901_17082020
RMM_ADELE 0.015mg/0.03mg TABLET_desogestrel_ethinylestradiol_Patient card_G03AA09_AA1006/01001_VREYA 0.035mg/2mg COATED TABLETS_ethinylestradiol_cyproterone acetate_Patient card_G03HB01_SUNYA 0.020ng/0.075mg COATED TABLETS_ethinylestradiol_gestodene_Patient card_G03AA10_AA1006/00701_NELYA TABLETS_ethinylestradiol_gestodene_Patient card_G03AA10_AA1006/00901_KATYA 0.030mg/0.075mg COATED TABLETS_ethinylestradiol_gestodene_G03AA10_Patient card_AA1006/00901_17082020
RMM_PRADAXA_dabigatran etexilate mesilate_Prescriber guide SPAF & DVT PE_B01AE07_EU/1/08/442/01-019_17082020
RMM_PRADAXA_dabigatran etexilate mesilate_Prescriber guide_pVTE_B01AE07_EU/1/08/442/001-019_17082020
RMM_THALIDOMIDE CELGENE_thalidomide_Brochure for healthcare professionals_L04AX02_EU/1/08/443/001_21082020
RMM_THALIDOMIDE CELGENE_thalidomide_Brochure for male patients_L04AX02_EU/1/08/443/001_21082020
RMM_THALIDOMIDE CELGENE_thalidomide_Brochure for patients WNCP_L04AX02_EU/1/08/443/001_21082020
RMM_THALIDOMIDE CELGENE_thalidomide_Brochure for patients WCBP_L04AX02_EU/1/08/443/001_21082020
RMM_XENIDATE XL 36mg PROLONGED RELEASE TABLETS_methylphenidate hydrochloride_Ċart_N06BA04_AA565/50302_25082020
RMM_XENIDATE XL 36mg PROLONGED RELEASE TABLETS_methylphenidate hydrochloride_Lista ta' kontroll 1_N06BA04_AA565/50302_25082020
RMM_XENIDATE XL 36mg PROLONGED RELEASE TABLETS_methylphenidate hydrochloride_Lista ta' kontroll 2_N06BA04_A565/50302_25082020
RMM_MABTHERA_rituximab_Patient alert card_L01XC02_EU/1/08/067/001-2_25082020
RMM_EPILIM_valproate sodium_Guide for healthcare professionals_N03AG01_AA082/04312-3_14092020
RMM_EPILIM_valproate sodium_Guide for patients_N03AG01_AA082/04312-3_14092020
RMM_ENTYVIO_vedolizumab_Brochure for healthcare professionals_L04AA33_EU/1/14/923/001-7_05102020
RMM_ENTYVIO_vedolizumab_Patient alert card_L04AA33_EU/1/14/923/001-7_05102020
RMM_BEOVU_brolucizumab_Guide for patients_J01CA06_EU/1/19/1417/001-2_07102020
RMM_ROACTEMRA_tocilizumab_Dosing guide_L04AC07_EU/1/08/492/001-010_14102020
RMM_ROACTEMRA_tocilizumab_Brochure for healthcare professionals_L04AC07_EU/1/08/492/001-010_14102020
RMM_ROACTEMRA_tocilizumab_Brochure for patients_L04AC07_EU/1/08/492/001-010_14102020
RMM_ROACTEMRA_tocilizumab_Patient alert card_L04AC07_EU/1/08/492/001-010_14102020
RMM_ESBRIET_pirfendione_Checklist for healthcare professionals_L04AX05_EU/1/11/667/001-021_19102020
RMM_TRUXIMA_rituximab_Brochure for healthcare professionals_L01XC02_EU/1/16/1167/001-2_09112020
RMM_TRUXIMA_rituximab_Brochure for patients_L01XC02_EU/1/16/1167/001-2_09112020
RMM_EXTRANEAL SOLUTION FOR PERITONEAL DIALYSIS_calcium chloride_icodextrin_magnesium chloride anhydous, sodium chloride_sodium lactate_Glucose monitor list_B05DA_MA161/01201_16112020
RMM_KINERET_anakinra_Booklet for healthcare professionals_L04AC03_EU/1/02/203/005-7_19112020
RMM_KINERET_anakinra_Booklet for patients_L04AC03_EU/1/02/203/005-7_19112020
RMM_LEMTRADA_alemtuzumab_Guide for healthcare professionals_L04AA34_EU/1/13/869/001_07122020
RMM_LEMTRADA_alemtuzumab_Checklist for healthcare professionals_L04AA34_EU/1/13/869/001_07122020
RMM_LEMTRADA_alemtuzumab_Guide for patients_L04AA34_EU/1/13/869/001_07122020
RMM_LEMTRADA_alemtuzumab_Karta ta' twissija tal-pazjent_L04AA34_EU/1/13/869/001_07122020
RMM_MAVENCLAD_cladribine_Guide for prescribers_L04AA40_EU/1/17/1212/001-006_17122020
RMM_MAVENCLAD_cladribine_Guide for patients_L04AA40-EU/1/17/1212/001-006_17122020
RMM_EXELON_rivastigmine_Patient diary_N06DA03_EU/1/98/066/001-034_03012019
RMM_ZOLEDRONIC ACID MYLAN_zoledronic acid_Patient reminder card_M05BA08_EU/1/12/786/001-4_04012019
RMM_REMICADE_infliximab_Patient reminder card_L04AB02_EU/1/99/116/001-5_10012019
RMM_GILENYA_fingolimod hydrochloride_Prescriber's checklist_L04AA27_EU/1/11/677/001-8_24012019
RMM_GILENYA_fingolimod hydrochloride_Patient reminder card_L04AA27_EU/1/11/677/001-8_24012019
RMM_GILENYA_fingolimod hydrochloride_Kartuna li tfakkar lill-pazjent_L04AA27_EU/1/11/677/001-8_24012019
RMM_GILENYA_fingolimod hydrochloride_Card for parents and caregivers_L04AA27_EU/1/11/677/001-8_24012019
RMM_GILENYA_fingolimod hydrochloride_Kartuna għall-ġenituri u l-kuraturi_L04AA27_EU/1/11/677/004-8_24012019
RMM_ROACTEMRA_tocilizumab_Brochure for healthcare professionals_L04AC07_EU/1/08/492/001-010_24012019
RMM_ROACTEMRA_tocilizumab_Dosing guide_L04AC07_EU/1/08/492/001-010_24012019
RMM_ROACTEMRA_tocilizumab_Brochure for patients_L04AC07_EU/1/08/492/001-010_24012019
RMM_ROACTEMRA_tocilizumab_Patient alert card_L04AC07_EU/1/08/492/001-010_24012019
RMM_NPLATE_romiplostim_Quick guide_B02BX04_EU/1/08/497/001-010_25012019
RMM_NPLATE_romiplostim_Preparation mat_B02BX04_EU/1/08/497/001-010_25012019
RMM_NPLATE_romiplostim_Dosing calculator_B02BX04_EU/1/08/497/001-010_25012019
RMM_NPLATE_romiplostim_Dose diary_B02BX04_EU/1/08/497/001-010_25012019
RMM_NPLATE_romiplostim_Checklist_B02BX04_EU/1/08/497/001-010_25012019
RMM_BLINCYTO_blinatumomab_Brochure for physicians_L01XC19_EU/1/15/1047/001_05042019
RMM_BLINCYTO_blinatumomab_Brochure for patients_L01XC19_EU/1/15/1047/001_05042019
RMM_BLINCYTO_blinatumomab_Patient card_L01XC19_EU/1/15/1047/001_05042019
RMM_TECENTRIQ_atezolizumab_Brochure for healthcare professionals_L01XC_EU/1/17/1120/001_10042019
RMM_TECENTRIQ_atezolizumab_Patient alert card_L01XC_EU/1/17/1120/001_10042019
RMM_OPDIVO_nivolumab_Guide for prescribing_EU/1/1/1014/001-3_02052019
RMM_BORTEZOMIB ACTAVIS 3.5mg POWDER FOR SOLUTION FOR INJECTION_bortezomib_Brochure for healthcare professionals_L01XX32_MA628/12801_06052019
RMM_FORXIGA_dapagliflozin_Guide for health care professionals_A10BK01_EU/1/12/795/001-010_13052019
RMM_FORXIGA_dapagliflozin_Guide for patient_A10BK01_EU/1/12/795/001-010_13052019
RMM_FORXIGA_dapagliflozin_Patient alert card_A10BK01_EU/1/12/795/001-010_13052019
RMM_CELLCEPT_mycophenolate mofetil_Guide for healthcare providers_L04AA06_EU/1/96/005/001-4_15052019
RMM_CELLCEPT_mycophenolate mofetil_Guide for patients_L04AA06_EU1/96/005/001-4_15052016
RMM_EMTRICITABINE_TENOFOVIR DISOPROXIL MYLAN_emtricitabine_tenofovir disoproxil maleate_Brochure for healthcare professionals_J05AR03_EU/1/16/1133/001-6_24052019
RMM_EMTRICITABINE_TENOFOVIR DISOPROXIL MYLAN_emtricitabine_tenofovir disoproxil maleate_Prescribers checklist_J05AR03_EU/1/16/1133/001-6_24052019
RMM_EMTRICITABINE_TENOFOVIR DISOPROXIL MYLAN_emtricitabine_tenofovir disoproxil maleate_Brochure for prescribers_J05AR03_EU/1/16/1133/001-6_24052019
RMM_EMTRICITABINE_TENOFOVIR DISOPROXIL MYLAN_emtricitabine_tenofovir disoproxil maleate_Guide for patients_J05AR03_EU/1/16/1133/001-6_24052019
RMM_EMTRICITABINE_TENOFOVIR DISOPROXIL MYLAN_emtricitbaine_tenofovir disoproxil maleate_Patient reminder card_J05AR03_EU/1/16/1133/001-6_24052019
RMM_CELLCEPT_mycophenolate mofetil_Guide for healthcare providers_L04AA06_EU/1/96/005/001-4_28052019
RMM_CELLCEPT_mycophenolate mofetil_Guide for patients_L04AA06_EU/1/96/005/011-4_28052019
RMM_KADCYLA_trastuzumab emtansine_Brochure for healthcare professionals_L01XC14_EU1/13/885/001-2_28052019
RMM_TRUXIMA_rituximab_Guide for health care professionals_L01XC02_EU/1/16/1167/001-2_06062019
RMM_TRUXIMA_rituximab_Brochure for patients_L01XC02_EU/1/16/1167/001-2_06062019
RMM_TRUXIMA_rituximab_Patient alert card_L01XC02_EU/1/16/1167/001-2_06062019
RMM_PRADAXA_dabigatran etexilate_Guide for prescribers_B01AE07_EU/1/08/442/001-019_24062019
RMM_HULIO_adalimumab_Guide for healthcare professionals_L04AB04_EU/1/18/1319/001-8_24062019
RMM_HULIO_adalimumab_Safety monograph_L04AB04_EU/1/18/1319/001-8_24062019
RMM_HULIO_adalimumab_Adult patient reminder card_L04AB04_EU/1/18/1319/001-8_24062019
RMM_HULIO_adalimumab_Children patient reminder card_L04AB04_EU/1/18/1319/001-8_24062019
RMM_ZOMETA_zoledronic acid_Patient reminder card_M05BA08_EU/1/01/176/001-9_24062019
RMM_ZOLEDRONIC ACID 4mg/5ml CONCENTRATE FOR SOLUTION FOR INFUSION_zoledronic acid_Patient reminder card_M05BA08_AA242/00901_02072019
RMM_MABTHERA_rituximab_Brochure for healthcare professionals_L01XC02_EU/1/98/067/001-4_08072019
RMM_MABTHERA_rituximab_Brochure for patients_L01XC02_EU/1/98/067/001-4_08072019
RMM_VALDOXAN_agomelatine_Guide for healthcare professionals_N06AX22_EU/1/08/499/002-8_15072019
RMM_VALDOXAN_agomelatine_Guide for patients_N06AX22_EU/1/08/499/002-8_15072019
RMM_UPTRAVI_selexipag_Guide for healthcare professionals_B01AC27_EU/1/15/1083/001-011_16072019
RMM_UPTRAVI_selexipag_Guide for patients_B01AC27_EU/1/15/1083/001-011_16072019
RMM_OPSUMIT_macitentan_Brochure for healthcare professionals_C02KX04_EU/1/13/893/001-3_19072019
RMM_OPSUMIT_macitentan_Prescribing checklist_C02KX04_EU/1/13/893/001-3_19072019
RMM_OPSUMIT_macitentan_FAQ Brochure_C02KX04_EU/1/13/893/001-3_19072019
RMM_OPSUMIT_macetantan_Patient card_C02KX04_EU/1/13/893/001-3_19072019
RMM_ENTYVIO_vedolizumab_Brochure for health care professionals_L04AA33_EU/1/14/923/001_22072019
RMM_ENTYVIO_vedolizumab_Patient alert card_L04AA33_EU/1/14/923/001_22072019
RMM_EMTRICITABINE_TENOFOVIR DISOPROXIL MYLAN_emtricitabine_tenofovir disoproxil maleate_Brochure for health care professionals_J05AR03_EU/1/16/1133/001-6_25072019
RMM_VIREAD_tenofovir disoproxil fumarate_Brochure for healthcare professionals_J05AF07_EU/1/01/200/001-9_26072019
RMM_MIRCERA_methyoxy polyethylene glycol-epoetin beta_Physician's guide_B03XA03_EU/1/07/400/008/22_20062019
RMM_ESBRIET_prifenidone_Safety checklist for prescribing physician_L04AX05_EU/1/11/667/001-021_20082019
RMM_PRADAXA_dabigatran etexilate_Prescariber guide_B01AE07_EU/1/08/442/001-019_26082019
RMM_PRADAXA_dabigatran etexilate_Prescriber guide_B01AE07_EU/1/08/442/001-019_26082019
RMM_ROACTEMRA_tocilizumab_Healthcare professional brochure_L04AC07_EU/1/08/492/001-010_30082019
RMM_ROACTEMRA_tocilizumab_Dosing guide_L04AC07_EU/1/08/492/001-010_30082019
RMM_ROACTEMRA_tocilizumab_Important safety information for patients_L04AC07_EU/1/08/492/001-010_30082019
RMM_ROACTEMRA_tocilizumab_Patient alert card_L04AC07_EU/1/08/492/001-010_30082019
RMM_EXJADE_deferasirox_Healthcare professional brochure_V03AC03_EU/1/06/356/001-022_02092019
RMM_EXJADE_deferasirox_Patient handbook_V03AC03_EU/1/06/356/001-022_02092019
RMM_EXJADE_deferasirox_Gwida għall-pazjent_V03AC03_EU/1/06/356/001-022_02092019
RMM_EXTRANEAL SOLUTION FOR PERITONEAL DIALYSIS_calcium chloride_icodextrin_magnesium chloride anhydrous_sodium chloride_sodium lactate_Glucose montior list_B05DA_MA161/01201_02092019
RMM_EXTRANEAL SOLUTION FOR PERITONEAL DIALYSIS_calcium chloride_icodextrin_magnesium chloride anhydrous_sodium chloride_sodium lactate_Patient alert card_B05DA_MA161/01201_02092019
RMM_EXTRANEAL SOLUTION FOR PERITONEAL DIALYSIS_calcium chloride_icodextrin_magnesium chloride anhydrous_sodium chloride_sodium lactate_Patient notes sticker_B05DA_MA161/01201_02092019
RMM_EXTRANEAL SOLUTION FOR PERITONEAL DIALYSIS_calcium chloride_icodextrin_magnesium chloride anhydrous_sodium chloride_sodium lactate_Patient sticker_B05DA_MA161/01201_02092019
RMM_REMICADE_infliximab_Patient reminder card_L04AB02_EU/1/99/116/001-5_04092019
RMM_MABTHERA_rituximab_Comparison card_L01XC03_EU/1/98/0067/001-4_16092019
RMM_MABTHERA_rituximab_Guide to supply, storage, handling and administration_L01XC03_EU/1/98/0067/001-4_16092019
RMM_REVLIMID_lenalidomide_Brochure for healthcare professionals_L04AX04_EU/1/07/391/001-014_25092019
RMM_REVLIMID_lenalidomide_Brochure for women patients of childbearing potential_L04AX04_EU/1/07/391/001-014_25092019
RMM_REVLIMID_lenalidomide_Brochure for women patients not of childbearing potential_L04AX04_EU/1/07/391/001-014_25092019
RMM_REVLIMID_lenalidomide_Brochure for male patients_L04AX04_EU/1/07/391/001-014_25092019
RMM_REVLIMID_lenalidomide_Patient card_L04AX04_EU/1/07/391/001-014_25092019
RMM_REVLIMiD_lenalidomide_Kard tal-pazjent_L04AX04_EU/1/07/391/001-014_25092019
RMM_ZOLEDRONIC ACID SEACROSS SOLUTION FOR INFUSION 5mg/100ml_zoledronic acid_Patient reminder card_M05BA08_AA770/07901_30092019
RMM_UPTRAVI_selexipag_Guide for healthcare professionals_B01AC27_EU/1/15/1083/001-011_2102019
RMM_UPTRAVI_selexipag_Guide for patients_B01AC27_EU/1/15/1083/001-011_2102019
RMM_TECENTRIQ_atezolizumab_Guide for healthcare professionals_L01XC_EU/1/17/1220/001_10102019
RMM_TECENTRIQ_atezolizumab_Patient alert card_L01XC_EU/1/17/1220/001_10102019
RMM_ACLASTA_zoledronic acid_Patient reminder card_M05BA08_EU/1/05/308/001-2_11102019
RMM_MULTAQ_dronedarone_Prescriber guide_C01BD07_EU/1/09/541/001-4_18102019
RMM_BENEPALI_etanercept_Slide deck for healthcare professional training_L04AB01_EU/1/15/1074/001-7_31102019
RMM_BRINEURA_cerliponase alfa_Dosing and administration guide_A16AB17_EU/1/17/1192/001_13112019
RMM_GILENYA_fingolimod hydrochloride_Physician's checklist_L04AA27_EU/1/11/677/001-8_14112019
RMM_GILENYA_fingolimod hydrochloride_Patient guide_L04AA27_EU/1/11/677/001-8_14112019
RMM_GILENYA_fingolimod hydrochloride_Gwida għall-pazjent_L04AA27_EU/1/11/677/001-8_14112019
RMM_GILENYA_fingolimod hydrochloride_Parents and caregivers guide_L04AA27_EU/1/11/677/001-8_14112019
RMM_GILENYA_fingolimod hydrochloride_Gwida għall-genituri u l-kuraturi_L04AA27_EU/1/11/677/001-8_14112019
RMM_GILENYA_fingolimod hydrochloride_Patient reminder card_L04AA27_EU/1/11/677/001-8_14112019
RMM_GILENYA_fingolimod hydrohcloride_Kartuna li tfakkar lill-pazjenti_L04AA27_EU/1/11/677/001-8_14112019
RMM_EPILIM_valproate sodium_Patient guide_N03AG01_AA082/04312-3_27112019
RMM_EPILIM_valproate sodium_Patient card_N03AG01_AA082/04312-3_27112019
RMM_OPDIVO_nivolumab_Risk minimisation information for healthcare professionals_L01XC17_EU/1/15/1014/001-2_28112019
RMM_ZOLEDRONIC ACID SEACROSS SOLUTION FOR INFUSION 5mg/100ml_zoledronic acid_Patient reminder card_M05BA08_AA770/07901_05122019
RMM_KEYTRUDA_pembrolizumab_Patient brochure_L01XC18_EU/1/15/1024/001-2_05122019
RMM_KEYTRUDA_pembrolizumab_Patient alert card_L01XC18_EU/1/15/1024/001-2_05122019
RMM_TENOFOVIR DISOPROXIL MYLAN_tenofovir disoproxil maleate_Brochure for prescribers_J05AF07_EU/1/16/1133/001-6_12122019
RMM_AGOMELATINE ARISTO 25mg FILM-COATED TABLETS_agomelatine_Prescribers guide_N06AX22_AA1209/01701_12122019
RMM_AGOMELATINE ARISTO 25mg FILM-COATED TABLETS_agomelatine_Patient alert card_N06AX22_AA1209/01701_12122019
RMM_AGOMELATINE ARISTO 25mg FILM-COATED TABLETS_agomelatine_Liver function monitoring scheme_N06AX22_AA1209/01701_12122019
RMM_ROACTEMRA_tocilizumab_Dosing guide_L04AC07_EU/1/08/492/001-010_12122019
RMM_ROACTEMRA_tocilizumab_Guide for healthcare professionals_L04AC07_EU/1/08/492/001-010_12122019
RMM_ROACTEMRA_tocilizumab_Brochure for patients_L04AC07_EU/1/08/492/001-010_12122019
RMM_ROACTEMRA_tocilizumab_Patient alert card_L04AC07_EU/1/08/492/001-010_12122019
RMM_IMPLANON NXT 68mg/IMPLANT_etonogestrel_Patient alert card_G03AC08_MA224/00701_27122019
RMM_LUCENTIS_ranibizumab_Patient booklet_S01LA04_EU/1/06/374/001-4_27122019
RMM_LUCENTIS_ranibizumab_Patient booklet audio script_S01LA04_EU/1/06/374/001-4_27122019
RMM_LUCENTIS_ranibizumab_Audio CD Book Script_S01LA04_EU/1/06/374/001-4_15012018
RMM_LUCENTIS_ranibizumab_Patient CNV Booklet_S01LA04_EU/1/06/374/001-4_15012018
RMM_LUCENTIS_ranibizumab_Physician Leaflet_S01LA04_EU/1/06/374/003_15012018
RMM_KEYTRUDA_pembrolizumab_Healthcare professional brochure_L01XC18_EU/1/15/1024/001-2_22012018
RMM_KEYTRUDA_pembrolizumab_Patient information brochure_L01XC18_EU/1/15/1024/001-2_22012018
RMM_KEYTRUDA_pembrolizumab_Patient alert card_L01XC18_EU/1/15/1024/001-2_22012018
RMM_PRADAXA_dabigatran etexilate_pVTE Prescriber Guide_B01AE07_EU/1/08/442/007_22012018
RMM_PRADAXA_dabigatran etexilate_SPAF DVT-PE Prescriber Guide_B01AE07_EU/1/08/442/007_22012018
RMM_TASIGNA_nilotinib_Health care professional brochure_L01XE08_EU/1/07/422/001-015_23012018
RMM_TASIGNA_nilotinib_Patient brochure_L01XE08_EU/1/07/422/001-015_23012018
RMM_TASIGNA_nilotinib_Informazzjoni lil pazjent_L01XE08_EU/1/07/422/001-015_23012018
RMM_ACLASTA_zoledronic acid_Physician guide_M05BA08_EU/1/05/308/001_26012018
RMM_ACLASTA_zoledronic acid_Patient guide_M05BA08_EU/1/05/308/001_26012018
RMM_ACLASTA_zoledronic acid_Patient reminder card_M05BA08_EU/1/05/308/001_26012018
RMM_EXTRANEAL SOLUTION FOR PERITONEAL DIALYSIS_icodextrin_sodium chloride_sodium-S-lactate_calcium chloride_magnesium chloride_sodium_calcium_magnesium_chloride_Glucose monitor list_B05DA_MA161/01201_19022019
RMM_GILENYA_fingolimod hydrochloride_Patient reminder card_L04AA27_EU/1/11/677/001-6_21022018
RMM_GILENYA_fingolimod hydrochloride_Kartuna li tfakkar lill-pazjent_L04AA27_EU/1/11/677/001-6_21022018
RMM_LEMTRADA_alemtuzumab_Healthcare professional guide_L04AA34_EU/1/13/869/001_01032018
RMM_LEMTRADA_alemtuzumab_Healthcare professional checklist_L04AA34_EU/1/13/869/001_01032018
RMM_LEMTRADA_alemtuzumab_Patient guide_L04AA34_EU/1/13/869/001_01032018
RMM_LEMTRADA_alemtuzumab_Patient alert card_L04AA34_EU/13/869/001_01032018
RMM_MYFORTIC_mycophenolate sodium_Guide for healthcare providers_L04AA06_MA088/04901-2_06032018
RMM_MYFORTIC_mycophenolate sodium_Guide for patients_L04AA06_MA088/04901-2_06032018
RMM_MYFORTIC_mycophenolate sodium_Guided questionnaire for health care providers_L04AA06_MA088/04901-2_06032018
RMM_MYFORTIC_mycophenolate sodium_Guided questionnaire for patients_L04AA06_MA088/04901-2_06032018
RMM_TRUVADA_emtricitabine_tenofovir disoproxil_Prescribers leaflet_J05AR03_EU/1/04/305/001-2_12032018
RMM_TRUVADA_emtricitabine_tenofovir disoproxil_Patient leaflet_J05AR03_EU/1/04/305/01-2_12032018
RMM_TRUVADA_emtricitabine_tenofovir disoproxil_Checklist for prescribers_J05AR03_EU/1/04/305/001-2_12032018
RMM_TRUVADA_emtricitabine_tenofovir disoproxil_Patient reminder card_J05AR03_EU/1/04/305/001-2_12032018
RMM_ROACTEMRA_tocilizumab_Patient brochure_L04AC07_EU/1/08/492/001-010_15032018
RMM_CELLCEPT_mycophenolate mofetil_Guide for healthcare providers_L04AA06_EU/1/96/005/001-4_09042018
RMM_CELLCEPT_mycophenolate mofetil_Guide for patients_L04AA06_EU/1/96/005/001-4_09042018
RMM_HEMLIBRA_emicizumab_Healthcare professional guide_B02BX06_EU/1/18/1271/001-4_25042018
RMM_HEMLIBRA_emicizumab_Laboratory professional guide_B02BX06_EU/1/18/1271/001-4_25042018
RMM_HEMLIBRA_emicizumab_Patient guide_B02BX06_EU/1/18/1271/001-4_25042018
RMM_HEMLIBRA_emicizumab_Patient alert card_B02BX06_EU/1/18/1271/001-4_25042018
RMM_EXJADE_deferasirox_Healthcare professional brochure_V03AC03_EU/1/06/356/001-022_04052018
RMM_EXJADE_deferasirox_Patient booklet_V03AC03_EU/1/06/356/001-22_04052018
RMM_EXJADE_deferasirox_Ktejjeb lil pazjent_V03AC03_EU/1/06/356/001-022_04052018
RMM_CUBICIN_daptomycin_Laboratory susceptibility testing leaflet_J01XX09_EU/1/05/328/001-4_24052018
RMM_CUBICIN_daptomycin_A guide to dosing_J01XX09_EU/1/05/328/001-4_24052018
RMM_EXELON_rivastigmine hydrogen tartrate_Patient Diary_N06DA03_EU/1/98/066/001-34_29052018
RMM_ROACTEMRA_tocilizumab_Healthcare professional brochure_L04AC07_EU/1/08/492/001-8_29052018
RMM_ROACTEMRA_tocilizumab_Administration guide_L04AC07_EU/1/08/492/001-8_29052018
RMM_ROACTEMRA_tocilizumab_Patient brochure_L04AC07_EU/1/08/492/001-8_29052018
RMM_ROACTEMRA_tocilizumab_Patient alert card_l04AC07_EU/1/8/492/001-8_29052018
RMM_ICLUSIG_ponatinib_Safety information for healthcare professionals_L01XE24_EU/1/13/839/001-6_12062018
RMM_EPILIM_valproate sodium_Healthcare professional guide_N03AG01_AA082/04312-13_19062018
RMM_EPILIM_valproate sodium_Annual risk acknowledgement form_N03AG01_AA082/04312-13_19062018
RMM_EPILIM_valproate sodium_Patient guide_N03AG01_AA082/04312-13_19062018
RMM_EPILIM_valproate sodium_Patient card_N03AG01_AA082/04312-13_19062018
RMM_KEYTRUDA_pembrolizumab_Healthcare professional brochure_L01XC18_EU/1/15/1024/001-2_13072018
RMM_KEYTRUDA_pembrolizumab_Patient guide_L01XC18_EU/1/15/1024/001-2_13072018
RMM_KEYTRUDA_pembrolizumab_Patient alert card_L01XC18_EU/1/15/1024/001-2_13072018
RMM_GILENYA_fingolimod hydrochloride_Prescribers checklist_L04AA27_EU/1/11/677/001-6_16072018
RMM_GILENYA_fingolimod hydrochloride_Patient reminder card_L04AA27_EU/1/11/677/001-6_16072018
RMM_GILENYA_fingolimod hydrochloride_Kartuna li tfakkar lill-pazjent_L04AA27_EU/1/11/677/001-6_16072018
RMM_ZOMETA_zoledronic acid_Patient reminder card_M05BA08_EU/1/01/176/001-9_23072018
RMM_YERVOY_ipilimumab_Guide for prescribing_L01XC11_EU/1/11/698/001-2_02082018
RMM_YERVOY_ipilimumab_Patient information guide_L01XC11_EU/1/11/698/001-2_02082018
RMM_YERVOY_ipilimumab_Patient alert card_L01XC11_EU/1/11/698/001-2_02082018
RMM_HUMIRA_adalimumab_Adult patient alert card_L04AB04_EU/1/03/256/001-027_08082018
RMM_HUMIRA_adalimumab_Paediatric patient alert card_L04AB04_EU/1/03/256/001-027_08082018
RMM_EYLEA_aflibercept_Prescriber guide_S01LA05_EU/1/12/797/001-2_14082018
RMM_ESBRIET_pirfenidone_Safety checklist_L04AX05_EU/1/11/667/001-021_29082018
RMM_ROACTEMRA_tocilizumab_Healthcare professional brochure_L04AC07_EU/1/08/492/001-010_29082018
RMM_ROACTEMRA_tocilizumab_Patient brochure_L04AC07_EU/1/08/492/001-010_29082018
RMM_ROACTEMRA_tocilizumab_Administration guide_L04AC07_EU/1/08/492/001-010_29082018
RMM_ROACTEMRA_tocilizumab_Patient alert card_L04AC07_EU/1/08/492/001-010_29082018
RMM_LUCENTIS_ranibizumab_Patient AMD guide_S01LA04_EU/1/06/374/001-4_05092018
RMM_LUCENTIS_ranibizumab_Patient AMD booklet_S01LA04_EU/1/06/374/001-4_05092018
RMM_LUCENTIS_ranibizumab_Patient DME guide_S01LA04_EU/1/06/374/001-4_05092018
RMM_LUCENTIS_ranibizumab_Patient DME booklet_S01LA04_EU/1/06/374/001-4_05092018
RMM_LUCENTIS_ranibizumab_Patient RVO guide_S01LA04_EU/1/06/374/001-4_05092018
RMM_LUCENTIS_ranibizumab_Patient RVO booklet_S01LA04_EU/1/06/374/001-4_05092018
RMM_XELJANZ_tofacitinib_Patient alert card_L04AA29_EU/1/17/1178/001-014_17092018
RMM_XELJANZ_tofacitinib_Checklist_L04AA29_EU/1/17/1178/001-014_17092018
RMM_XELJANZ_tofacitinib_Prescriber brochure_L04AA29_EU/1/17/1178/001-014_17092018
RMM_OPDIVO_nivolumab_Guide for prescribing_L01XC17_EU/1/15/1014/001-3_19092018
RMM_OPDIVO_nivolumab_Patient alert card_L01XC17_EU/1/15/1014/001-3_19092018
RMM_KINERET_anakinra_Healthcare professionals guide_L04AC03_EU/1/02/203/005-7_20092018
RMM_KINERET_anakinra_Patient information booklet_L04AC03_EU/1/02/203/005-7_20092018
RMM_KINERET_anakinra_Patient card_L04AC03_EU/1/02/203/005-7_20092018
RMM_MYFORTIC_mycophenolic acid_Guide for healthcare providers_L04AA06_MA1249/00301-2_02102018
RMM_MYFORTIC_mycophenolic acid_Guide for patients_L04AA06_MA1249/00301-2_02102018
RMM_TECENTRIQ_atezolizumab_Brochure for healthcare professionals_L01XC_EU/1/17/1220/001_10102018
RMM_TECENTRIQ_atezolizumab_Patient alert card_L01XC_EU/1/17/1220/001_10102018
RMM_STELARA_ustekinumab_Healthcare professionals leaflet_L04AC05_EU/1/08/494/001-5_19102018
RMM_STELARA_ustekinumab_Patients leaflet_L04AC05_EU/1/08/494/001-5_19102018
RMM_STELARA_ustekinumab_Instructions for healthcare professionals_L04AC05_EU/1/08/494/001-5_19102018
RMM_STELARA_ustekinumab_Instructions for patients_L04AC05_EU/1/08/494/001-5_19102018
RMM_STELARA_ustekinumab_Poster for healthcare professionals_L04AC05_EU/1/08/494/001-5_19102018
RMM_STELARA_ustekinumab_Poster for patients_L04AC05_EU/1/08/494/001-5_19102018
RMM_DAXAS_roflumilast_Information for prescribers_R03DX07_EU/1/10/636/001-8_22102018
RMM_DAXAS_roflumilast_Patient card_R03DX07_EU/1/10/636/001-8_22102018
RMM_MABTHERA_rituximab_Patient alert card_L01XC02_EU/1/98/067/001-4_26102018
RMM_BONVIVA_ibandronic acid_Patient reminder card_M05BA06_EU/1/03/265/003-6_01112018
RMM_REMSIMA_infliximab_Brochure for healthcare professionals_L04AB02_EU/1/13/853/001-5_13112018
RMM_REMSIMA_infliximab_Infusion card_L04AB02_EU/1/13/853/001-5_13112018
RMM_REMSIMA_infliximab_Patient alert card_L04AB02_EU/1/13/853/001-5_13112018
RMM_REMSIMA_infliximab_Safety sheet_L04AB02_EU/1/13/853/001-5_13112018
RMM_REMSIMA_infliximab_Screening sheet_L04AB02_EU/1/13/853/001-5_13112018
RMM_KADCYLA_trastuzumab emtansine_EU Healthcare professional information_L01XC14_EU/1/13/885/001-2_21112018
RMM_ACITRETIN CAPSULES 25mg_acitretin_Physician Checklist_D05BB02_AA085/00601_DECUTAN 10mg SOFT CAPSULES_isotretinoin_Physician Checklist_D10BA01_MA628/17401_DECUTAN 20mg SOFT CAPSULES_isotretinoin_Physician Checklist_D10BA01_MA628/17402_ISOTRETINOIN SOFT CAPSULES 10mg_isotretinoin_Physician Checklist_D10BA01_AA908/13201_ISOTRETINOIN SOFT CAPSULES 20mg_isotretinoin_Physician Checklist_D10BA01_AA908/13202_NEOTIGASON_acitretin_Physician Checklist_D05BB02_MA628/04101-2_23112018
RMM_ACITRETIN CAPSULES 25mg_acitretin_Patient reminder card_D05BB02_AA085/00601_DECUTAN 10mg SOFT CAPSULES_isotretinoin_Patient reminder card_D10BA01_MA628/17401_DECUTAN 20mg SOFT CAPSULES_isotretinoin_Patient reminder card_D10BA01_MA628/17402_ISOTRETINOIN SOFT CAPSULES 10mg_isotretinoin_Patient reminder card_D10BA01_AA908/13201_ISOTRETINOIN SOFT CAPSULES 20mg_isotretinoin_Patient reminder card_D10BA01_AA908/13202_NEOTIGASON_acitretin_Patient reminder card_D05BB02_MA628/04101-2_23112018
RMM_XARELTO_rivaroxaban_Prescriber guide_B01AF01_EU/1/08/472/001-049_29112018
RMM_BLINCYTO_blinatumomab_Brochure for physicians_L01XC19_EU/1/15/1047/001_29112018
RMM_BLINCYTO_blinatumomab_Brochure for pharmacists_L01XC19_EU/1/15/1047/001_29112018
RMM_BLINCYTO_blinatumomab_Brochure for patients_L01XC19_EU/1/15/1047/001_29112018
RMM_BLINCYTO_blinatumomab_Brochure for nurses_L01XC19_EU/1/15/1047/001_29112018
RMM_ISOTRETINOIN 5mg capsules_isotretinoin_Physician's guide to dispensing isotretinoin_D10BA01_AA1282/00101_18122018
RMM_ISOTRETINOIN 5mg capsules_isotretinoin_Pharmacist's guide to dispensing_D10BA01_AA1282/00101_18122018
RMM_ISOTRETINOIN 5mg capsules_isotretinoin_Brochure on contraception_D10BA01_AA1282/00101_18122018
RMM_ISOTRETINOIN 5mg capsules_isotretinoin_Patient information brochure_D10BA01_AA1282/00101_18122018
RMM_ISOTRETINOIN 5mg capsules_isotretinoin_Checklist for prescribing to female patients_D10BA01_AA1282/00101_18122018
RMM_ISOTRETINOIN 5mg capsules_isotretinoin_Acknowledgement form_D10BA01_AA1282/00101_18122018
RMM_COLTRAMYL_thiocolchicoside_Healthcare professional guide_M03BX05_MA082/00801_MUSCORIL 4mg HARD CAPSULES_thiocolchicoside_Healthcare professional guide_M03BX05_AA082/09801_RELIEF CAPSULES HARD 4mg_thiocolchicoside_Healthcare professional guide_M03BX05_AA729/17501_RELIEF SOLUTION FOR INJECTION 4mg/2ml_thiocolchicoside_Healthcare professional guide_M03BX05_AA729/175003_21122018
RMM_COLTRAMYL_thiocolchicoside_Patient card_M03BX05_MA082/00801_MUSCORIL 4mg HARD CAPSULES_thiocolchicoside_Patient card_M03BX05_AA082/09801_RELIEF CAPSULES HARD 4mg_thiocolchicoside_Patient card_M03BX05_AA729/17501_RELIEF SOLTUION FOR INJECTION 4mg/2ml_thiocolchicoside_Patient card_M03BX05_AA729/17503_21122018
RMM_ERIVEDGE_vismodegib_PPP_Healthcare professional brochure_L01XX43_EU/1/13/848/001_02012017
RMM_ERIVEDGE_vismodegib_PPP_Healthcare professional reminder card_L01XX43_EU/1/13/848/001_02012017
RMM_ERIVEDGE_vismodegib_PPP_Patient brochure_L01XX43_EU/1/13/848/001_02012017
RMM_ERIVEDGE_vismodegib_PPP_Patient reminder card_L01XX43_EU/1/13/848/001_02012017
RMM_ERIVEDGE_vismodegib_PPP_Verification of counselling form_L01XX43_EU/1/13/848/001_02012017
RMM_ENBREL_etanercept_Patient alert card_L04AB01_EU/1/99/126/002-022_10012017
RMM_TASIGNA_nilotinib_Health care professional brochure_L01XE08_EU/1/07/422/008_20012017
RMM_INFLECTRA_infliximab_Screening sheet_L04AB02_EU/1/13/854/001-5_24012017
RMM_CAPRELSA_vandetanib_Educational material for healthcare professional_L01XE_EU/1/11/749/001-2_24012017
RMM_CAPRELSA_vandetanib_Dosing and monitoring guide_L01XE_EU/1/11/749/001-2_24012017
RMM_CAPRELSA_vandetanib_Patient alert card_L01XE_E/U/1/11/749/001-2_24012017
RMM_YERVOY_ipilimumab_Guide for prescribing_L01XC11_EU/1/11/698/001-2_27012017
RMM_YERVOY_ipilimumab_Patient information guide_L01XC11_EU/1/11/698/001-2_27012017
RMM_LUCENTIS_ranibizumab_Patient booklet_S01LA04_EU/1/06/374/001-4_30012017
RMM_LUCENTIS_ranibizumab_Patient booklet audio CD script_S01LA04_EU/1/06/374/001-4_30012017
RMM_LUCENTIS_ranibizumab_Physician leaflet_S01LA04_EU/1/06/374/003_30012017
RMM_GILENYA_fingolimod_Kartuna li tfakkar lill-pazjent_L04AA27_EU/1/11/677/005_03022017
RMM_GILENYA_fingolimod_Patient reminder card_L04AA27_EU/1/11/677/005_03022017
RMM_GILENYA_fingolimod_Prescriber's checklist prior to prescribing_L04AA27_EU/1/11/677/005_03022017
RMM_CUBICIN_daptomycin_A guide to dosing_J01XX09_EU/1/05/328/001-4_08022017
RMM_CUBICIN_daptomycin_Antibiotic susceptibility testing leaflet_J01XX09_EU/1/05/328/001-4_08022017
RMM_HUMIRA_adalimumab_A resource guide for healthcare professionals_L04AB04_EU/1/03/256/001-19_14022017
RMM_HUMIRA_adalimumab_Safety monograph_L04AB04_EU/1/03/256/001-19_14022017
RMM_MULTAQ_dronedarone_Prescriber guide_C01BD07_EU/1/09/591/001-4_15022017
RMM_DARZALEX_daratumumab_Guide for healthcare professionals_L01XC24_EU/1/16/1101/001-2_16022017
RMM_DARZALEX_daratumumab_Guide for health care professionals working at the blood bank_L01XC24_EU/1/16/1101/001-2_16022017
RMM_DARZALEX_daratumumab_Patient card_L01XC24_EU/1/16/1101/001-2_16022017
RMM_XALKORI_crizotinib_Therapeutic management guide_L01XE16_EU/1/12/793/001-4_20022017
RMM_XALKORI_crizotinib_Patient booklet_L01XE16_EU/1/12/793/001-4_20022017
RMM_OPDIVO_nivolumab_Healthcare professional guide_L01XC17_EU/1/15/1014/001-2_28022017
RMM_OPDIVO_nivolumab_Patient alert card_L01XC17_EU/1/15/1014/001-2_28022017
RMM_KADCYLA_trastuzumab emtansine_EU healthcare professional information_L01XC14_EU/1/13/885/001-2_07032017
RMM_MYFORTIC_mycophenolic acid_Guide for healthcare providers_L04AA06_MA088/04901-2_07032017
RMM_MYFORTIC_mycophenolic acid_Guide for patients_L04AA06_MA088/04901-2_07032017
RMM_MYFORTIC_mycophenolic acid_Guided questionnaire for patients_L04AA06_MA088/04901-2_07032017
RMM_MYFORTIC_mycophenolic acid_Guided questionnaire for health care providers_L04AA06_MA088/04901-2_07032017
RMM_OLUMIANT_baricitinib_Guide for healthcare professionals_L04AA37_EU/1/16/1170/001-016_14032017
RMM_OLUMIANT_baricitinib_Patient alert card_L04AA37_EU/1/16/1170/001-016_14032017
RMM_EXJADE_deferasirox_Healthcare professional brochure_V03AC03_EU/1/06/356/014_17_20032017
RMM_EXJADE_deferasirox_Patient handbook_V03AC03_EU/1/06/356/014_17_20032017
RMM_BOSENTAN ACCORD_bosentan_Prescriber guide_C02KX01_MA054/08501-2_30032017
RMM_BOSENTAN ACCORD_bosentan_Patient information booklet_C02KX01_MA054/08501-2_30032017
RMM_EXJADE_deferasirox_Ktejjeb għall-pazjent_V03AC03_EU/1/06/356/001-19_13042017
RMM_REVLIMID_lenalidomide_Healthcare Professional Brochure_L04AX04_EU/1/07/391/001-011_18042017
RMM_REVLIMID_lenalidomide_Patient Brochure Male_L04AX04_EU/1/07/391/001-011_18042017
RMM_REVLIMID_lenalidomide_Patient Brochure WCBP_L04AX04_EU/1/07/391/001-011_18042017
RMM_REVLIMID_lenalidomide_Patient Brochure WNCBP_L04AX04_EU/1/07/391/001-011_18042017
RMM_REVLIMID_lenalidomide_Patient Card_L04AX04_EU/1/07/391/001-011_18042017
RMM_MABTHERA_rituximab_Healthcare professional brochure_L01XC02_EU/1/98/067/001-4_18042017
RMM_MABTHERA_rituximab_Patient brochure_L01XC02_EU/1/98/067/001-4_18042017
RMM_MABTHERA_rituximab_Comparison card_L01XC02_EU/1/98/067/001-4_18042017
RMM_MABTHERA_rituximab_Step-by-step guide_L01XC02_EU/1/98/067/001-4_18042017
RMM_EXELON_rivastigmine hydrogen tartrate_Patient diary_N06DA03_EU/1/98/066/019-034_21042017
RMM_XELJANZ_tofacitinib citrate_Prescriber brochure_L04AA29_EU/1/17/1178/001-4_12052017
RMM_XELJANZ_tofacitinib citrate_Patient alert card_L04AA29_EU/1/17/1178/001-4_12052017
RMM_XELJANZ_tofacitinib citrate_Prescriber treatment initiation checklist_L04AA29_EU/1/17/1178/001-4_12052017
RMM_XELJANZ_tofacitinib citrate_Prescriber treatment maintenance checklist_L04AA29_EU/1/17/1178/001-4_12052017
RMM_ESBRIET_pirfenidone_Safety checklist for prescribing physician_L04AX05_EU/1/11/667/001-3_16052017
RMM_ENTYVIO_vendolizumab_Safety information_L04AA33_EU/1/14/923/001_22052017
RMM_ENTYVIO_vendolizumab_Patient alert card_L04AA33_EU/1/14/923/001_22052017
RMM_VIREAD_tenofovir disoproxil fumarate_HIV paediatric educational brochure_J05AF07_EU/1/01/200/001-9_24052017
RMM_VALDOXAN_agomelatine_Information for healthcare professionals_N06AX22_EU/1/08/499/002-8_15062017
RMM_VALDOXAN_agomelatine_Patient booklet_N06AX22_EU/1/08/499/002-8_15062017
RMM_EPILIM CHRONO 200mg PROLONGED-RELEASE TABLETS_valproate sodium_Checklist for prescribers and patients_N03AG01_MA082/04301_25092017
RMM_THALIDOMIDE CELGENE_thalidomide_Information for male patients taking Thalidomide Celgene_L04AX02_EU/1/08/443/001_31052017
RMM_THALIDOMIDE CELGENE_thalidomide_Information for women of non-childbearing potential taking Thalidomide Celgene_L04AX02_EU/1/08/443/001_31052017
RMM_THALIDOMIDE CELGENE_thalidomide_Information for women of childbearing potential taking Thalidomide Celgene_L04AX02_EU/1/08/443/001_31052017
RMM_ROACTEMRA_tocilizumab_Step-by-step dosing and administration guide_L04AC07_EU/1/08/492/001-8_31052017
RMM_ROACTEMRA_tocilizumab_Important efficacy and safety information for healthcare professionals_L04AC07_EU/1/08/492/001-8_31052017
RMM_GILENYA_fingolimod hydrochloride_Prescriber's checklist prior to prescribing_L04AA27_EU/1/11/677/005_14062017
RMM_ZOMETA_zoledronic acid_Patient reminder card_M05BA08_EU/1/01/176/001-9_15062017
RMM_BLINCYTO_blinatumomab_Brochure for physicians_L01XC_EU/1/15/1047/001_12072017
RMM_BLINCYTO_blinatumomab_Brochure for pharmacists_L01XC_EU/1/15/1047/001_12072017
RMM_BLINCYTO_blinatumomab_Brochure for nurses_L01XC_EU/1/15/1047/001_12072017
RMM_BLINCYTO_blinatumomab_Brochure for patients and caregivers_L01XC_EU/1/15/1047/001_12072017
RMM_BLINCYTO_blinatumomab_Patient card_L01XC_EU/1/15/1047/001_12072017
RMM_ENBREL_etanercept_Patient alert card_L04AB01_EU/1/99/126/002-22_21072017
RMM_TYSABRI_natalizumab_Physician information and management guidelines for multiple sclerosis patients on TYSABRI therapy_L04AA23_EU/1/06/346/001_27072017
RMM_TASIGNA_nilotinib_Healthcare professional brochure_L01XE08_EU/1/07/422/008_01082017
RMM_TASIGNA_nilotinib_Patient brochure_L01XE08_EU/1/07/422/008_01082017
RMM_EYLEA_aflibercept_Prescriber guide_S01LA05_EU/1/12/797/001-2_23082017
RMM_EYLEA_aflibercept_Patient guide_S01LA05_EU/1/12/797/001-2_23082017
RMM_OPDIVO_nivolumab_Guide for Prescribing_L01XC17_EU/1/15/1014/001-2_24082017
RMM_OPDIVO_nivolumab_Patient alert card_L01XC17_EU/1/15/1014/001-2_24082017
RMM_LUCENTIS_ranibizumab_Patient AMD booklet_S01LA04_EU/1/06/374/001-4_04092017
RMM_LUCENTIS_ranibizumab_Patient DME booklet_S01LA04_EU/1/06/374/001-4_04092017
RMM_LUCENTIS_ranibizumab_Patient RVO booklet_S01LA04_EU/1/06/374/001-4_04092017
RMM_LUCENTIS_ranibizumab_Patient AMD guide script_S01LA04_EU/1/06/374/001-4_04092017
RMM_LUCENTIS_ranibizumab_Patient DME guide script_S01LA04_EU/1/06/374/001-4_04092017
RMM_LUCENTIS_ranibizumab_Patient RVO guide script_S01LA04_EU/1/06/374/001-4_04092017
RMM_LUCENTIS_ranibizumab_Pre-filled syringe guidelines_S01LA04_EU/1/06/374/003_04092017
RMM_BENEPALI_etanercept_Quick reference guide_L04AB01_EU/1/15/1074/001-7_11092017
RMM_BENEPALI_etanercept_Slide deck for healthcare professional training guide_L04AB01_EU/1/1/15/1074/001-7_11092017
RMM_EPILIM CHRONO 200mg PROLONGED RELEASE TABLETS_valproate sodium_Checklist for prescribers and patients_N03AG01_MA082/04301_EPILIM LIQUID 200mg/5ml ORAL SOLUTION_valproate sodium_Checklist for prescribers and patients_N03AG01_MA082/04311_EPLIM INTRAVENOUS 400mg POWDER AND SOLVENT FOR SOLUTION FOR INJECTION OR INFUSION_valproate sodium_Checklist for prescribers and patients_N03AG01_MA082/04303_25092017
RMM_TECENTRIQ_atezolizumab_Brochure for healthcare professionals_L01XC_EU/1/17/1220/001_28092017
RMM_TECENTRIQ_atezolizumab_Patient alert card_L01XC_EU/1/17/1220/001_28092017
RMM_NEBIDO_testosterone undecanoate_Educational brochure_G03BA03_MA185/02701_02102017
RMM_ROACTEMRA_tocilizumab_Safety information for healthcare professionals_L04AC07_EU/1/08/492/001-8_05102017
RMM_ROACTEMRA_tocilizumab_Step-by-step dosing and administration guide_L04AC07_EU/1/08/492/001-8_05102017
RMM_ROACTEMRA_tocilizumab_Patient brochure_L04AC07_EU/1/08/492/007-8_05102017
RMM_ROACTEMRA_tocilizumab_Patient alert card_L04AC07_EU/1/08/492/001-8_05102017
RMM_VELCADE_bortezomib_Reconstitution, dosing and administration booklet_L01XX32_EU/1/04/274/001-2_01112017
RMM_VELCADE_bortezomib_Reconstitution poster_L01XX32_EU/1/04/274/001-2_01112017
RMM_YERVOY_ipilimumab_Guide for prescribing_L01XC11_EU/1/11/698/001-2_14112017
RMM_YERVOY_ipilimumab_Patient information guide_L01XC11_EU/1/11/698/001-2_14112017
RMM_YERVOY_ipilimumab_Patient alert card_L01XC11_EU/1/11/698/001-2_14112017
RMM_OPDIVO_nivolumab_Guide for prescribing_L01XC_EU/1/15/1014/001-2_17112017
RMM_OPDIVO_nivolumab_Patient alert card_L01XC_EU/1/15/1014/001-2_17112017
RMM_OLUMIANT_baricitinib_Patient alert card_L04AA37_EU/1/16/1170/001-016_01122017
RMM_XARELTO_rivaroxaban_Prescriber guide_B01AF01_EU/1/08/472/001-45_19122017
RMM_ARIPIPRAZOLE SANDOZ_aripiprazole_Information brochure for health care professionals_N05AX12_EU/1/15/1029/001-061_25012016
RMM_ARIPIPRAZOLE SANDOZ_aripiprazole_Information brochure for patients and caregivers_N05AX12_EU/1/15/1029/001-061_25012016
RMM_REVLIMID_lenalidomide_Healthcare Professional Brochure_L04AX04_EU/1/07/391/001-9_12022016
RMM_REVLIMID_lenalidomide_Patient Brochure Male_L04AX04_EU/1/07/391/001-9_12022016
RMM_REVLIMID_lenalidomide_Patient Brochure WCBP_L04AX04_EU/1/07/391/001-9_12022016
RMM_REVLIMID_lenalidomide_Patient Brochure WNCBP_L04AX04_EU/1/07/391/001-9_12022016
RMM_REVLIMID_lenalidomide_Patient Card_L04AX04_EU/1/07/391/001-9_12022016
RMM_REVLIMID_lenalidomide_Template for letter to other treating physicians_L04AX04_EU/1/07/391/001-9_12022016
RMM_REVLIMID_lenalidomide_Treatment Initiation Form Men_L04AX04_EU/1/07/391/001-9_12022016
RMM_REVLIMID_lenalidomide_Treatment Initiation Form WCBP_L04AX04_EU/1/07/391/001-9_12022016
RMM_REVLIMID_lenalidomide_Treatment Initiation Form WNCBP_L04AX04_EU/1/07/391/001-9_12022016
RMM_GILENYA_fingolimod_Kartuna li tfakkar lill-pazjent_L04AA27_EU/1/11/677/001-006_17022016
RMM_GILENYA_fingolimod_Patient reminder card_L04AA27_EU/1/11/677/001-006_17022016
RMM_GILENYA_fingolimod_Prescriber's checklist prior to prescribing_L04AA27_EU/1/11/677/001-006_17022016
RMM_VECTIBIX_panitumumab_Physician Education Brochure_L01XC08_EU/1/07/423/001-3_18022016
RMM_CAPRELSA_vandetanib_Healthcare professional educational material_L01XE12_EU/1/11/749/001-2_03032016
RMM_CAPRELSA_vandetanib_Patient alert card_L01XE12_EU/1/11/749/001-2_03032016
RMM_XALKORI_crizotinib_Healthcare professional booklet_L01XE16_EU/1/12/793/001-4_09032016
RMM_XALKORI_crizotinib_Patient booklet_L01XE16_EU/1/12/793/001-4_09032016
RMM_ZYPADHERA_olanzapine pamoate monohydrate_Healthcare professional reconstitution training slides_N05AH03_EU/1/08/479/001-3_10032016
RMM_ZYPADHERA_olanzapine pamoate monohydrate_Training slides_N05AH03_EU/1/08/479/001-3_10032016
RMM_ZYPADHERA_olanzapine pamoate monohydrate_Patient Card_N05AH03_EU/1/08/479/001-3_10032016
RMM_MYFORTIC_mycophenolic acid_Guide for healthcare providers_L04AA06_MA088/04901-2_14032016
RMM_MYFORTIC_mycophenolic acid_Guide for patients_L04AA06_MA088/04901-2_14032016
RMM_MYFORTIC_mycophenolic acid_Guided questionnaire for health care providers_L04AA06_MA088/04901-2_14032016
RMM_MYFORTIC_mycophenolic acid_Guided questionnaire for patients_L04AA06_MA088/04901-2_14032016
RMM_ARIPIPRAZOLE ACCORD_aripiprazole_Healthcare professional FAQ brochure_N05AX12_EU/1/15/1045/001-026_15032016
RMM_ARIPIPRAZOLE ACCORD_aripiprazole_Patients_caregiver information brochure_N05AX12_EU/1/15/1045/001-026_15032016
RMM_TROBALT_retigabine_Physician guide_N03AX21_EU/1/11/681/001-2_4-12_17032016
RMM_EPILIM_valproate sodium_Patient card_N03AG01_MA082/04301-3_12042016
RMM_TYSABRI_natalizumab_Physician information and management guidelines for multiple sclerosis patients on TYSABRI therapy_L04AA23_EU/1/06/346/001_12042016
RMM_TYSABRI_natalizumab_Patient alert card_L04AA23_EU/1/06/346/001_12042016
RMM_TYSABRI_natalizumab_Treatment initiation form_L04AA23_EU/1/06/346/001_12042016
RMM_TYSABRI_natalizumab_Treatment discontinuation form_L04AA23_EU/1/06/346/001_12042016
RMM_SYMBICORT_budesonide_formoterol fumarate dihydrate_Asthma booklet adult_R03AK07_MA046/00901-3_26042016
RMM_SYMBICORT_budesonide_formoterol fumarate dihydrate_Parents guide booklet_R03AK07_MA046/00901-3_26042016
RMM_SYMBICORT_budesonide_formoterol fumarate dihydrate_Patient User guide_R03AK07_MA046/00901-3_26042016
RMM_REMICADE_infliximab_Important safety information_L04AB02_EU/1/99/116/001-5_11052016
RMM_REMICADE_infliximab_Patient alert card_L04AB02_EU/1/99/116/001-5_11052016
RMM_PRADAXA_dabigatran etexilate_SPAF DVT & PE Prescriber guide_B01AE07_EU/1/08/442/007_011_03062016
RMM_PRADAXA_dabigatran etexilate_VTE Prescriber guide_B01AE07_EU/1/08/442/001_003_005_007_03062016
RMM_ENBREL_etanercept_Flipchart_L04AB01_EU/1/99/126/019-21_06062016
RMM_ENBREL_etanercept_Patient brochure_L04AB01_EU/1/99/126/019-21_06062016
RMM_LEMILVO_aripiprazole_Healthcare professional FAQ brochure_N05AX12_MA628/13101-7_08062016
RMM_LEMILVO_aripiprazole_Patient_caregiver brochure_N05AX12_MA628/13101-7_08062016
RMM_TARCEVA_erlotinib_Healthcare professional leaflet_L01XE03_EU/1/05/311/001-3_13062016
RMM_VORICONAZOLE ACCORD_voriconazole_Healthcare professional question & answer brochure_J02AC03_EU/1/13/835/001-030_14062016
RMM_VORICONAZOLE ACCORD_voriconazole_Healthcare professional checklist_J02AC03_EU/1/13/835/001-030_14062016
RMM_VORICONAZOLE ACCORD_voriconazole_Patient alert card_J02AC03_EU/1/13/835/001-030_14062016
RMM_OPDIVO_nivolumab_Immune-Related Adverse Reaction Management Guide_L01XC17_EU/1/15/1014/001-2_20062016
RMM_OPDIVO_nivolumab_Patient alert card_L01XC17_EU/1/15/1014/001-2_20062016
RMM_EXELON_rivastigmine hydrogen tartrate_Patient diary_N06DA03_EU/1/98/066/019-034_22062016
RMM_XEOMIN_Clostridium botulinum neurotoxin type A_Information for health care professionals_M03AX01_MA025/00701-3_30062016
RMM_XEOMIN_Clostridium botulinum neurotoxin type A_Patient information sheet_M03AX01_MA025/00701-3_30062016
RMM_PAMIDRONATE DISODIUM 3mg/ml STERILE CONCENTRATE_pamidronate disodium_Patient reminder card_M05BA03_AA734/00901_07072016
RMM_TYSABRI_natalizumab_Physician information and management guidelines for multiple sclerosis patients on TYSABRI therapy_L04AA23_EU/1/06/346/001_19072016
RMM_ZOMETA_zoledronic acid_Patient reminder card_M05BA08_EU/1/01/176/001-009_29072016
RMM_TOUJEO_insulin glargine_Guide for healthcare professionals_A10AE04_EU/1/00/133/001-036_01082016
RMM_TOUJEO_insulin glargine_Guide for patients_A10AE04_EU/1/00/133/001-036_01082016
RMM_OZURDEX 700 micrograms INTRAVITREAL IMPLANT IN APPLICATOR_dexamethasone_An injector's guide to OZURDEX_S01BA01_EU/1/10/638/001_08082016
RMM_OZURDEX 700 micrograms INTRAVITREAL IMPLANT IN APPLICATOR_dexamethasone_A patient guide to OZURDEX therapy_S01BA01_EU/1/10/638/001_08082016
RMM_OZURDEX 700 micrograms INTRAVITREAL IMPLANT IN APPLICATOR_dexamethasone_A patient guide to OZURDEX therapy audioscript_S01BA01_EU/1/10/638/001_08082016
RMM_ELIQUIS_apixaban_Prescriber guide_B01AF02_EU/1/11/691/001-015_08082016
RMM_SYMBICORT_budesonide_formoterol fumarate dihydrate_Patient information leaflet_R03AK07_MA046/00901-3_16082016
RMM_EYLEA_aflibercept_Prescriber guide_S01LA05_EU/1/12/797/001-2_23082016
RMM_IMNOVID_pomalidomide_Safety advice and pregnancy prevention programme brochure_L04AX06_EU/1/13/850/001-4_23082016
RMM_IMNOVID_pomalidomide_Brochure for male patients_L04AX06_EU/1/13/850/001-4_23082016
RMM_IMNOVID_pomalidomide_Brochure for women patients of childbearing potential_L04AX06_EU/1/13/850/001-4_23082016
RMM_IMNOVID_pomalidomide_Brochure for women patients not of childbearing potential_L04AX06_EU/1/13/850/001-4_23082016
RMM_TARCEVA_erlotinib_Healthcare professional leaflet_L01XE03_EU/1/05/311/001-3_23082016
RMM_GONAL-f_follitropin alfa_Patient Guide_G03GA05_EU/1/95/001/005, 021, 025-035_29082016
RMM_GONAL-f_follitropin alfa_Video storyboard_G03GA05_EU/1/95/001/005, 021, 025-035_29082016
RMM_SYMBICORT_budesonide_formoterol fumarate dihydrate_Asthma action plan_R03AK07_MA046/00901-3_01092016
RMM_SYMBICORT_budesonide_formoterol fumarate dihydrate_Action plan emergency card_R03AK07_MA046/00901-3_01092016
RMM_SYMBICORT_budesonide_formoterol fumarate dihydrate_Question and answer leaflet_R03AK07_MA046/00901-3_01092016
RMM_TRUVADA_emtricitabine_tenofovir disoproxil_Prescribers leaflet_J05AR03_EU/1/04/305/001-2_07092016
RMM_TRUVADA_emtricitabine_tenofovir disoproxil_Checklist for prescribers_J05AR03_EU/1/04/305/001-2_07092016
RMM_TRUVADA_emtricitabine_tenofovir disoproxil_Patient leaflet_J05AR03_EU/1/04/305/001-2_07092016
RMM_TRUVADA_emtricitabine_tenofovir disoproxil_Patient reminder card_J05AR03_EU/1/04/305/001-2_07092016
RMM_KINERET_anakinra_Healthcare professional booklet_L04AC03_EU/1/02/203/001-7_22092016
RMM_KINERET_anakinra_Patient booklet_L04AC03_EU/1/02/203/001-7_22092016
RMM_LUCENTIS_ranibizumab_AMD Patient Booklet_S01LA04_EU/1/06/374/001-4_22092016
RMM_LUCENTIS_ranibizumab_AMD Audio CD Script_S01LA04_EU/1/06/374/001-4_22092016
RMM_LUCENTIS_ranibizumab_CNV Patient Booklet_S01LA04_EU/1/06/374/001-4_22092016
RMM_LUCENTIS_ranibizumab_CNV Audio CD Script_S01LA04_EU/1/06/374/001-4_22092016
RMM_LUCENTIS_ranibizumab_RVO Patient Booklet_S01LA04_EU/1/06/374/001-4_22092016
RMM_LUCENTIS_ranibizumab_RVO Audio CD Script_S01LA04_EU/1/06/374/001-4_22092016
RMM_LUCENTIS_ranibizumab_Physician Leaflet_S01LA04_EU/1/06/374/003_22092016
RMM_LUCENTIS_ranibizumab_Intravitreal injection guidelines_S01LA04_EU/1/06/374/003_22092016
RMM_LUCENTIS_ranibizumab_Pre-filled syringe preparation guidelines_S01LA04_EU/1/06/374/003_22092016
RMM_LUCENTIS_ranibizumab_Pre-filled syringe video script_S01LA04_EU/1/06/374/003_22092016
RMM_CAPRELSA_vandetanib_Healthcare professional educational material_L01XE12_EU/1/11/749/001-2_26092016
RMM_CAPRELSA_vandetanib_Patient alert card_L01XE12_EU/1/11/749/001-2_26092016
RMM_EXJADE_deferasirox_Ktejjeb lil pazjent_V03AC03_EU/1/06/356/001-10_28092016
RMM_EXJADE_deferasirox_Healthcare professional brochure_V03AC03_EU/1/06/356/003_5_04102016
RMM_TASIGNA_nilotinib_Patient brochure_L01XE08_EU/1/07/422/001-014_04102016
RMM_ROACTEMRA_tocilizumab_Healthcare professionals brochure_L04AC07_EU/1/08/492/001-8_31102016
RMM_YERVOY_ipilimumab_Guide for prescribing_L01XC11_EU/1/11/698/001-2_16112016
RMM_YERVOY_ipilimumab_Patient information guide_L01XC11_EU/1/11/698/001-2_16112016
RMM_YERVOY_ipilimumab_Patient alert card_L01XC11_EU/1/11/698/001-2_16112016
RMM_KEYTRUDA_pembrolizumab_Healthcare professional frequently asked questions_L01XC18_EU/1/15/1024/001-2_21112016
RMM_KEYTRUDA_pembrolizumab_Patient brochure_L01XC18_EU/1/15/1024/001-2_21112016
RMM_KEYTRUDA_pembrolizumab_Patient alert card_L01XC18_EU/1/15/1024/001-2_21112016
RMM_ACLASTA_zoledronic acid_Physician's guide_M05BA08_EU/1/05/308/001-2_02122016
RMM_ACLASTA_zoledronic acid_Patient's guide_M05BA08_EU/1/05/308/001-2_02122016
RMM_ACLASTA_zoledronic acid_Patient reminder card_M05BA08_EU/1/05/308/001-2_02122016
RMM_KIVEXA_abacavir_lamivudine_Information for healthcare professionals_J05AR02_EU/1/04/298/002-3_16122016
RMM_BONDRONAT_ibandronic acid_Patient reminder card_M05BA06_EU/1/96/012/004_11_16122016
RMM_BONVIVA_ibandronic acid_Patient reminder card_M05BA06_EU/1/03/265/005_16122016
RMM_EPILIM_sodium valproate_Guide for healthcare professionals_N03AG01_AA082/04311_20012015
RMM_EPILIM_sodium valproate_Patient information booklet_N03AG01_AA082/04311_20012015
RMM_LUCENTIS_ranibizumab_AMD Patient Audio CD Script_S01LA04_EU/1/06/374/001-4_02022015
RMM_LUCENTIS_ranibizumab_AMD Patient booklet_S01LA04_EU/1/06/374/001-4_02022015
RMM_LUCENTIS_ranibizumab_Physicians leaflet_S01LA04_EU/1/06/374/001_02022015
RMM_LUCENTIS_ranibizumab_CNV Patient booklet_S01LA04_EU/1/06/374/001-4_02022015
RMM_LUCENTIS_ranibizumab_CNV Patient Audio CD script_S01LA04_EU/1/06/374/001-4_02022015
RMM_LUCENTIS_ranibizumab_DME Patient Audio CD script_S01LA04_EU/1/06/374/001-4_02022015
RMM_LUCENTIS_ranibizumab_DME Patient booklet_S01LA04_EU/1/06/374/001-4_02022015
RMM_LUCENTIS_ranibizumab_RVO Patient booklet_S01LA04_EU/1/06/374/001-4_02022015
RMM_VIREAD_tenofovir disoproxil fumarate_HBV paediatric educational brochure_J05AF07_EU/1/01/200/001-9_11022015
RMM_VIREAD_tenofovir disoproxil fumarate_HIV paediatric educational brochure_J05AF07_EU/1/01/200/001-9_11022015
RMM_VIREAD_tenofovir disoproxil fumarate_HBV renal educational brochure_J05AF07_EU/1/01/200/001-9_11022015
RMM_VIREAD_tenofovir disoproxil fumarate_HIV renal educational brochure_J05AF07_EU/1/01/200/001-9_11022015
RMM_XARELTO_rivaroxaban_Patient card_B01AF01_EU/1/08/472/011-21_11022015
RMM_XARELTO_rivaroxaban_Prescriber guide_B01AF01_EU/1/08/472/011-21_11022015
RMM_ZIAGEN_abacavir_Information for healthcare professionals_J05AF06_EU/1/99/112/001-2_04032015
RMM_EYLEA_aflibercept_Prescriber guide_S01LA05_EU/1/12/797/001-2_16032015
RMM_EYLEA_aflibercept_Patient brochure_S01LA05_EU/1/12/797/001-2_16032015
RMM_ESBRIET_pirfenidone_Safety checklist for prescribing physician_L04AX05_EU/1/11/667/001-3_25032015
RMM_ELIQUIS_apixaban_Prescriber guide_B01AF02_EU/1/11/691/001-015_25032015
RMM_ELIQUIS_apixaban_Patient alert card_B01AF02_EU/1/11/691/001-015_25032015
RMM_ELIQUIS_apixaban_Kartuna ta' twissija għal-pazjent_B01AF02_EU/1/11/691/001-015_25032015
RMM_KADCYLA_trastuzumab emtansine_Single page key points_L01XC14_EU/1/13/885/001-2_08042015
RMM_KADCYLA_trastuzumab emtansine_EU healthcare professional information_L01XC14_EU/1/13/885/001-2_08042015
RMM_KADCYLA_trastuzumab emtansine_Key points to remember_L01XC14_EU/1/13/885/001-2_08042015
RMM_ROACTEMRA_tocilizumab_Important efficacy and safety information for healthcare professionals-rheumatoid arthrtis_L04AC07_EU/1/08/492/001-8_21042015
RMM_ROACTEMRA_tocilizumab_Important efficacy and safety information for healthcare professionals_sJIA and PJIA_L04AC07_EU/1/08/492/001-8_21042015
RMM_ROACTEMRA_tocilizumab_Patient alert card_L04AC07_EU/1/08/492/001-8_21042015
RMM_ROACTEMRA_tocilizumab_RoActemra infusion dosing for rheumatoid arthritis_L04AC07_EU/1/08/492/001-6_21042015
RMM_ROACTEMRA_tocilizumab_RoActemra intravenous (IV) dosing for polyarticular juvenile idiopathic arthritis (PJ1A)_L04AC07_EU/1/08/492/001-6_21042015
RMM_ROACTEMRA_tocilizumab_sJIA MAS Card_L04AC07_EU/1/08/492/001-8_21042015
RMM_ROACTEMRA_tocilizumab_Step-by-Step Dosing and administration guide-pJIA and sJIA_L04AC07_EU/1/08/492/001-6_21042015
RMM_ROACTEMRA_tocilizumab_Step-by-Step Dosing and administration guide_rheumatoid arthritis_L04AC07_EU/1/08/492/001-8_21042015
RMM_ESMYA_ulipristal acetate_ESMYA (ulipristal acetate): Physician guide to prescribing_G03XB02_EU/1/12/750/001-5_29042015
RMM_ESMYA_ulipristal acetate_ESMYA (ulipristal acetate): Pathologist guide_G03XB02_EU/1/12/750/001-5_29042015
RMM_LEVOSERT 20 MICROGRAMS/24 HOURS INTRAUTERINE DELIVERY SYSTEM_levonorgestrel_Prescriber check list_G02BA03_MA1031/00401_04052015
RMM_LEVOSERT 20 MICROGRMAS/24 HOURS INTRAUTERINE DELIVERY SYSTEM_levonorgestrel_Patient card_G02BA03_MA1031/00401_04052015
RMM_VISTABEL_4_ALLERGAN UNITS_0.1ml_POWDER FOR SOLUTION FOR INJECTION_Botulinum toxin type A_A guide for patients treated with VISTABEL_MO3AX01_MA102/00601_14052015
RMM_VISTABEL_4_ALLERGAN UNITS_0.1ml_POWDER FOR SOLUTION FOR INJECTION_Botulinum toxin type A_Healthcare professional information_M03AX01_MA102/00601_14052015
RMM_BOTOX_Botulinum toxin type A_100 Allergan Units_Patient guide_M03AX01_MA102/00301-3_15052015
RMM_BOTOX_Botulinum toxin type A_100 Allergan Units_Healthcare professional information_M03AX01_MA102/00301-3_15052015
RMM_COLTRAMYL_Thiocolchicoside_Patient card_M03BX05_MA082/00801_21052015
RMM_COLTRAMYL_Thiocolchicoside_Healthcare professional guide for systemic use of thiocolchicoside_M03BX05_MA082/00801_21052015
RMM_THALIDOMIDE_CELGENE_thalidomide_Thalidomide Celgene patient card_L04AX02_EU/1/08/443/001_21052015
RMM_THALIDOMIDE_CELGENE_thalidomide_Information for women of childbearing potential and their partners taking Thalidomide Celgene_L04AX02_EU/1/08/443/001_21052015
RMM_THALIDOMIDE_CELGENE_thalidomide_Information for women of non-childbearing potential taking Thalidomide Celgene_L04AX02_EU/1/08/443/001_21052015
RMM_THALIDOMIDE_CELGENE_thalidomide_Information for male patients taking Thalidomide Celgene_L04AX02_EU/1/08/443/001_21052015
RMM_THALIDOMIDE_CELGENE_thalidomide_Information for healthcare professionals prescribing or dispensing Thalidomide Celgene_L04AX02_EU/1/08/443/001_21052015
RMM_TYSABRI_natalizumab_Physician information and management guidelines for multiple sclerosis patients on TYSABRI therapy_L04AA23_EU/1/06/346/001_22062015
RMM_TYSABRI_natalizumab_Treatment initiation form_L04AA23_EU/1/06/346/001_22062015
RMM_XEOMIN_Clostridium Botulinum neurotoxin type A_Information for healthcare professionals_M03AX01_MA025/00701-2_14072015
RMM_XEOMIN_Clostridium Botulinum neurotoxin type A_Patient information sheet_M03AX01_MA025/00701-2_14072015
RMM_PARACETAMOL ACTAVIS 10 mg/ml solution for infusion_paracetamol_Dosing guide_N02BE01_AA628/10901_30072015
RMM_PARACETAMOL ACTAVIS 10 mg/ml solution for infusion_paracetamol_Poster_N02BE01_AA628/10901_30072015
RMM_GILENYA_fingolimod_Prescriber's checklist: summary of recommendations_L04AA27_EU/1/11/677/001-006_04082015
RMM_ZOLEDRONIC ACID HOSPIRA_zoledronic acid_Patient reminder card_M05BA08_EU/1/12/800/001-004_11082015
RMM_OPDIVO_nivolumab_Immune-Related Adverse Reaction Management Guide_L01XC17_EU/1/15/1014/001-2_11082015
RMM_OPDIVO_nivolumab_Patient alert card_L01XC17_EU/1/15/1014/001-2_11082015
RMM_TASIGNA_nilotinib_Healthcare professional brochure_L01XE08_EU/1/07/422/001-14_18082015
RMM_TASIGNA_nilotinib_Patient brochure_L01XE08_EU/1/07/422/001-14_18082015
RMM_TRIOMEL PERIPHERAL 4g_l nitrogen 700 kcal_l with elecrolytes, emulsion for infusion_User guide poster_B05BA10_MA161/03501_21082015
RMM_ZOMETA_zoledronic acid_Patient reminder card_M05BA08_EU/1/01/176/001-9_25082015
RMM_EXELON_rivastigmine hydrogen tartrate_Patient diary_N06DA03_EU/1/98/066/019-034_26082015
RMM_IMNOVID_pomalidomide_Brochure for male patients_L04AX06_EU/1/13/850/001-4_26082015
RMM_IMNOVID_pomalidomide_Brochure for women patients not of childbearing potential_L04AX06_EU/1/13/850/001-4_26082015
RMM_IMNOVID_pomalidomide_Brochure for women patients of childbearing potential_L04AX06_EU/1/13/850/001-4_26082015
RMM_IMNOVID_pomalidomide_Safety advice and PPP brochure_L04AX06_EU/1/13/850/001-4_26082015
RMM_ZOLEDRONIC ACID ACCORD_zoledronic acid_Patient reminder card_M05BA08_EU/1/13/834/001-3_07092015
RMM_REMSIMA _infliximab_CT-P13 100mg_Infusion card_L04AB02_EU/1/13/853/001-5_15092015
RMM_REMSIMA_infliximab_CT-P13 100mg_Pediatric Brochure_L04AB02_EU/1/13/853/001-5_15092015
RMM_REMSIMA_infliximab_CT-P13 100mg_Safety sheet_L04AB02_EU/1/13/853/001-5_15092015
RMM_REMSIMA_infliximab_CT-P13 100mg_Screening sheet_L04AB02_EU/1/13/853/001-5_15092015
RMM_LUCENTIS_ranibizumab_Physician Leaflet_S01LA04_EU/1/06/374/001-3_25092015
RMM_LUCENTIS_ranibizumab_Lucentis pre-filled syringe intravitreal injection guidelines_S01LA04_EU/1/06/374/003_25092015
RMM_PRADAXA_dabigatran etexilate_SPAF DVT&PE Educational Pack_B01AE07_EU/1/08/442/007_011_25092015
RMM_PRADAXA_dabigatran etexilate_SPAF DVT&PE Prescriber Guide_B01AE07_EU/1/08/442/007_011_25092015
RMM_PRADAXA_dabigatran etexilate_VTE Educational Pack_B01AE07_EU/1/08/442/001_003_005_007_25092015
RMM_PRADAXA_dabigatran etexilate_VTE Prescriber guide_B01AE07_EU/1/08/442/001_003_005_007_25092015
RMM_HUMIRA_adalimumab_Safety Monograph_L04AB04_EU/1/03/256/001-019_02112015
RMM_HUMIRA_adalimumab_TB Brochure_L04AB04_EU/1/03/256/001-019_02112015
RMM_HUMIRA_adalimumab_Adult patient information card_L04AB04_EU/1/03/256/001-019_02112015
RMM_HUMIRA_adalimumab_Pediatric patient information card_L04AB04_EU/1/03/256/001-019_02112015
RMM_EYLEA_aflibercept_Prescriber guide_S01LA05_EU/1/12/797/001-2_30112015
RMM_EYLEA_aflibercept_Patient brochure_S01LA05_EU/1/12/797/001-2_30112015
RMM_ACLASTA_zoledronic acid_Patient reminder card_M05BA08_EU/1/05/308/001-2_02122015
RMM_CELLCEPT_mycophenolate mofetil_Guide for Healthcare Providers_L04AA06_EU/1/96/005/001-6_09122015
RMM_CELLCEPT_mycophenolate mofetil_Guide for Patients_L04AA06_EU/1/96/005/001-6_09122015
RMM_OPDIVO_nivolumab_Immune-Related Adverse Reaction Management Guide_L01XC17_EU/1/15/1014/001-2_14122015
RMM_OPDIVO_nivolumab_Patient alert card_L01XC17_EU/1/15/1014/001-2_14122015
RMM_ESBRIET_pirfenidone_Safety checklist for prescribing physician_L04AX05_EU/1/11/667/001-3_15122015
RMM_STRATTERA_atomoxetine_Physician's guide and tools_N06BA09_MA001/00102_14012014
RMM_COMBODART_dutasteride tamsulosin_PSA leaflet_G04CA52_MA300/00401_17012014
RMM_BOTOX_botulinum toxin A_CM_Patient_RM_Guide_M03AX01_MA102/00301_17012014
RMM_BOTOX_botulinum toxin A_NMD_Patient_RM_Guide_M03AX01_MA102/00301_17012014
RMM_BOTOX_botulinum toxin A_URO_Patient_RM_Guide_M03AX01_MA102/00301_17012014
RMM_NEBIDO_testosterone undecanoate_Healthcare professional educational brochure_G03BA03_MA185/02701_23012014
RMM_XARELTO_rivaroxaban_Prescriber guide_B01AF01_EU/1/08/472/001-39_7022014
RMM_VELCADE_bortezomib_Educational material_L01XX32_EU/1/04/274/001_12022014
RMM_JAYDESS_levonorgestrel_Ectopic fact sheet_G02BA03_MA513/05301_13022014
RMM_JAYDESS_levonorgestrel_Educational material for healthcare professionals_G02BA03_MA513/05301_13022014
RMM_DECUTAN_isotretinoin_Pharmacist's brochure_D10BA01_MA155/00501-2_17022014
RMM_DECUTAN_isotretinoin_Checklist for prescribing to female patients_D10BA01_MA155/00501-2_17022014
RMM_DECUTAN_isotretinoin_Acknowledgement form for women of childbearing potential_D10BA01_MA155/00501-2_17022014
RMM_KADCYLA_trastuzumab emtansin_EU healthcare professional information_L01XC14_EU/1/13/885/001-2_17022014
RMM_KADCYLA_trastuzumab emtansin_Key points to remember_L01XC14_EU/1/13/885/001-2_17022014
RMM_KADCYLA_trastuzumab emtansin_Single page diff-Sim_L01XC14_EU/1/13/885/001-2_17022014
RMM_KADCYLA_trastuzumab emtansin_EU healthcare professional information feedback form_L01XC14_EU/1/13/885/001-2_17022014
RMM_ACLASTA_zoledronic acid_Patient's leaflet_M05BA08_EU/1/05/308/001-2_24022014
RMM_ACLASTA_zoledronic acid_Physician's reminder card_M05BA08_EU/1/05/308/001-2_24022014
RMM_PERFALGAN_paracetamol_Dosing tool_N02BE01_AA244/28801_21032014
RMM_PRILIGY_dapoxetine_Healthcare professional brochure_G04BX14_MA1022/00101-2_24032014
RMM_PRILIGY_dapoxetine_Patient brochure_G04BX14_MA1022/00101-2_24032014
RMM_TROBALT_retigabine_Physicians' guide_N03AX21_EU/1/11/681/001-2_4-12_01042014
RMM_LEMTRADA_alemtuzumab_Healthcare professional guide_L04AA34_EU/1/13/869/001_04042014
RMM_LEMTRADA_alemtuzumab_Healthcare professional checklist_L04AA34_EU/1/13/869/001_04042014
RMM_LEMTRADA_alemtuzumab_Patient guide_L04AA34_EU/1/13/869/001_04042014
RMM_LEMTRADA_alemtuzumab_Patient alert card_L04AA34_EU/1/13/869/001_04042014
RMM_AUBAGIO_teriflunomide_Healthcare professional education_discussion guide_L04AA31_EU/1/13/838/001-5_04042014
RMM_AUBAGIO_teriflunomide_Patient card_L04AA31_EU/1/13/838/001-5_04042014
RMM_MABTHERA_rituximab_Step-by-step roll fold leaflet_L01XC02_EU/1/98/067/003_16042014
RMM_MABTHERA_rituximab_Comparison card_L01XC02_EU/1/98/067/001-3_16042014
RMM_COMBINED HORMONAL CONTRACEPTIVES_desogestrel_gestodene_norgestimate_etonogestrel_drospirenone_dienogest_chlormadinone_nomegestrol_Prescriber checklist_04062014
RMM_COMBINED HORMONAL CONTRACEPTIVES_desogestrel_gestodene_norgestimate_etonogestrel_drospirenone_dienogest_chlormadinone_nomegestrol_Patient Information card_04062014
RMM_IMNOVID_pomalidomide_Brochure for male patients_L04AX06_EU/1/13/850/001-4_09062014
RMM_IMNOVID_pomalidomide_Brochure for WPNCP_L04AX06_EU/1/13/850/001-4_09062014
RMM_IMNOVID_pomalidomide_Brochure for WPCP_L04AX06_EU/1/13/850/001-4_09062014
RMM_IMNOVID_pomalidomide_Healthcare professionals brochure_L04AX06_EU/1/13/850/001-4_09062014
RMM_IMNOVID_pomalidomide_Patient card_L04AX06_EU/1/13/850/001-4_09062014
RMM_IMNOVID_pomalidomide_Pregnancy capture form_L04AX06_EU/1/13/850/001-4_09062014
RMM_JETREA_ocriplasmin_Patient booklet_S01XA22_EU/1/13/819/001-2_09062014
RMM_IV IRON_Fuljett lil Pazjenti_B03AC_10062014
RMM_IV IRON_Patient Leaflet_B03AC_10062014
RMM_IV IRON_Healthcare professional leaflet_B03AC_10062014
RMM_IV IRON_Fuljett lit-tobba_B03AC_10062014
RMM_ROACTEMRA_tocilizumab_Patient alert card Malta_L04AC07_EU/1/08/492/001-8_23062014
RMM_ROACTEMRA_tocilizumab_Healthcare professional brochure_L04AC07_EU/1/08/492/001-8_23062014
RMM_ROACTEMRA_tocilizumab_Step-by-Step dosing and administration guide-rheumatoid arthritis_L04AC07_EU/1/08/492/001-8_23062014
RMM_HUMIRA_adalimumab_Pediatric patient information card_L04AB04_EU/1/03/256/001-19_24062014
RMM_HUMIRA_adalimumab_TB brochure_L04AB04_EU/1/03/256/001-19_24062014
RMM_HUMIRA_adalimumab_Safety monograph_L04AB04_EU/1/03/256/001-19_24062014
RMM_HUMIRA_adalimumab_Patient alert card_L04AB04_EU/1/03/256/001-19_24062014
RMM_REQUIP MODUTAB_ropinirole_Requip Modutab switch dosage card_N04BC04_MA192/00106_09072014
RMM_VFEND_voriconazole_Healthcare professional question & answer brochure_J02AC_EU/1/02/212/001-027_10072014
RMM_VFEND_voriconazole_Healthcare professional checklist_J02AC_EU/1/02/212/001-027_10072014
RMM_VFEND_voriconazole_Kartuna ta' twissija għal-pazjent_J02AC_EU/1/02/212/001-027_10072014
RMM_VFEND_voriconazole_Patient alert card_J02AC_EU/1/02/212/001-027_10072014
RMM_EYLEA_aflibercept_Prescriber guide_S01LA05_EU/1/12/797/001-2_10072014
RMM_EYLEA_aflibercept_Patient's booklet_S01LA05_EU/1/12/797/001-2_10072014
RMM_PRADAXA_dabigatran etexilate_SPAF Educational pack_B01AE07_EU/1/08/442/007_011_14072014
RMM_PRADAXA_dabigatran etexilate_SPAF Prescriber guide_B01AE07_EU/1/08/442/007_011_14072014
RMM_PRADAXA_dabigatran etexilate_VTE Educational pack_B01AE07_EU/1/08/442/001_003_005_007_14072014
RMM_PRADAXA_dabigatran etexilate_VTE Prescriber guide_B01AE07_EU/1/08/442/001_003_005_007_14072014
RMM_PRADAXA_dabigatran etexilate_DVT PE Prescribers guide_B01AE07_EU/1/08/442/007_011_14072014
RMM_PRADAXA_dabigatran etexilate_DVT PE Educational pack_B01AE07_EU/1/08/442/007_011_14072014
RMM_PROTELOS_strontium ranelate_Prescriber checklist_M05BX03_EU/1/04/288/001-6_01082014
RMM_PROTELOS_strontium ranelate_Prescriber guide and checklist_M05BX03_EU/1/04/288/001-6_01082014
RMM_PROTELOS_strontium ranelate_Patient alert card_M05BX03_EU/1/04/288/001-6_01082014
RMM_VIBATIV_telavancin_Healthcare professional educational pack_J01XA03_EU/1/11/705/001-2_15082014
RMM_ELIQUIS_apixaban_Kartuna ta' twissija għal pazjent_B01AF02_EU/1/11/691/001-015_22082014
RMM_TARCEVA_erlotinib_Healthcare professional leaflet_L01XE34_EU/1/05/311/001-3_27082014
RMM_XALKORI_crizotinib_Healthcare professional booklet_L01XE16_EU/1/12/793/001-4_17092014
RMM_XALKORI_crizotinib_Patient booklet_L01XE16_EU/1/12/793/001-4_17092014
RMM_REVOLADE_eltrombopag_Healthcare professional booklet_B02BX05_EU/1/10/612/001-012_29092014
RMM_REVOLADE_eltrombopag_Patient booklet_B02BX05_EU/1/10/612/001-012_29092014
RMM_STAMARIL_yellow fever virus strain 17D_Healthcare professionals leaflet_J07BL01_MA573/00601_21102014
RMM_EXJADE_deferasirox_Physician Brochure NTDT_V03AC03_EU/1/06/356/003_005_23102014
RMM_VALDOXAN_agomelatine_Liver function monitoring scheme_N06AX22_EU/1/08/499/001-008_28102014
RMM_VALDOXAN_agomelatine_Patient booklet_N06AX22_EU/1/08/499/001-008_28102014
RMM_VALDOXAN_agomelatine_Information for healthcare professionals_N06AX22_EU/1/08/499/001-008_28102014
RMM_TRIOMEL_amino acid solution_User Guide Poster_B05BA10_MA161/03501_30102014
RMM_MABTHERA_rituximab_Patient alert card_L01XC02_EU/1/98/067/001-2_01122014
RMM_XARELTO_rivaroxaban_Patient card_B01AF01_EU/1/08/472/001-39_02122014
RMM_SIMPONI_golimumab_Educational brochure_L04AB06_EU/1/09/546/001-008_12122014
RMM_SIMPONI_golimumab_Important safety information sheet_L04AB06_EU/1/09/546/001-8_12122014
RMM_SIMPONI_golimumab_Patient alert card_L04AB06_EU/1/09/546/001-8_12122014
RMM_ENBREL_etanercept_Administration guide_L04AB01_EU/1/99/126/019-21_15122014
RMM_ENBREL_etanercept_Flip Chart_L04AB01_EU/1/99/126/019-21_15122014
RMM_ENBREL_etanercept_Safety information sheet_L04AB01_EU/1/99/126/001-22_15122014
RMM_EXJADE_deferasirox_Dosing and monitoring guidelines_V03AC03_EU/1/06/356/003_005_15122014
RMM_EXJADE_deferasirox_Prescriber guide_V03AC03_EU/1/06/356/003_005_15122014
RMM_EXJADE_deferasirox_Il-fuljett ta' tagħrif tal-pazjent_V03AC03_EU/1/06/356/003_005_15122014
RMM_VISTABEL 4 ALLERGAN UNITS_0.1ml_POWDER FOR SOLUTION FOR INJECTION_Botulinum toxin type A_Patient guide_M03AX01_MA102/00601_15122014
RMM_ZOMETA_zoledronic acid_Patient reminder card_M05BA08_EU/1/01/176/001-9_15122014
RMM_EXJADE_deferasirox_Il-fuljett ta' tagħrif tal-pazjent_V03AC03_EU/1/06/356/001-019_02012013
RMM_TARCEVA_erlotinib_Healthcare professional leaflet_L01XE03_EU/1/05/311/001-3_28012013
RMM_NPLATE_romiplostim_Physician guide_B02BX04_EU/1/08/497/001-8_06022013
RMM_GILENYA_fingolimod_Kartuna li tfakkar lill-pazjent_L04AA27_EU/1/11/677/001-006_18022013
RMM_GILENYA_fingolimod_Patient reminder card_L04AA27_EU/1/11/677/001-006_18022013
RMM_JAYDESS_levonorgestrel_Ectopic pregnancy fact sheet_G02BA03_MA513/05301_21022013
RMM_JAYDESS_levonorgestrel_Educational Material for Healthcare professionals_G02BA03_MA513/05301_21022013
RMM_MABTHERA_rituximab_Healthcare professional leaflet_L01XC02_EU/1/98/067/001-4_21022013
RMM_MABTHERA_rituximab_Patient leaflet_L01XC02_EU/1/98/067/001-4_21022013
RMM_NPLATE_romiplostim_Home administration training pack_B02BX04_EU/1/08/497/001-8_21022013
RMM_NPLATE_romiplostim_Checklist tearsheet_B02BX04_EU/1/08/497/001-8_21022013
RMM_NPLATE_romiplostim_Self-administration diary_B02BX04_EU/1/08/497/001-8_21022013
RMM_NPLATE_romiplostim _Preparation Mat_B02BX04_EU/1/08/497/001-8_21022013
RMM_NPLATE_romiplostim_Quick guide_B02BX04_EU/1/08/497/001-8_21022013
RMM_CUBICIN_daptomycin_Dosage guide_J01XX09_EU/1/05/328/001-4_28022013
RMM_CUBICIN_daptomycin_Laboratory susceptibility testing leaflet_J01XX09_EU/1/05/328/001-4_28022013
RMM_PERFALGAN_paracetamol_Poster_N02BE01_AA244/28801_28022013
RMM_VIREAD_tenofovir disoproxil fumarate_HBV paediatric educational brochure_J05AF07_EU/1/01/200/001-9_20042013
RMM_VIREAD_tenofovir disoproxil fumarate_HIV paediatric educational brochure_J05AF07_EU/1/01/200/001-9_20042013
RMM_ZOLEDRONIC ACID HOSPIRA_zoledronic acid_Physician reminder card_M05BA08_EU/1/12/800/001-4_22052013
RMM_ZOLEDRONIC ACID HOSPIRA_zoledronic acid_Patient guide_M05BA08_EU/1/12/800/001-4_22052013
RMM_PRADAXA_dabigatran etexilate_SPAF Educational pack_B01AE07_EU/1/08/442/007_011_28052013
RMM_PRADAXA_dabigatran etexilate_SPAF Prescriber guide_B01AE07_EU/1/08/442/007_011_28052013
RMM_PRADAXA_dabigatran etexilate_VTE Educational pack_B01AE07_EU/1/08/442/001_003_005_007_28052013
RMM_PRADAXA_dabigatran etexilate_VTE Prescriber guide_B01AE07_EU/1/08/442/001_003_005_007_28052013
RMM_MABTHERA_rituximab_Healthcare professional leaflet_L01XC02_EU/1/98/067/001_29052013
RMM_MABTHERA_rituximab_Patient alert card_L01XC02_EU/1/98/067/001_29052013
RMM_MABTHERA_rituximab_Patient Leaflet_L01XC02_EU/1/98/067/001_29052013
RMM_REVLIMID_lenalidomide_Patient Brochure Male_L04AX04_EU/1/07/391/001-9_6072013
RMM_REVLIMID _lenalidomide_Patient Brochure WCBP_L04AX04_EU/1/07/391/001-9_6072013
RMM_REVLIMID_lenalidomide_Patient Brochure WNCBP_L04AX04_EU/1/07/391/001-9_6072013
RMM_REVLIMID_lenalidomide_Patient card Malta_L04AX04_EU/1/07/391/001-9_6072013
RMM_REVLIMID_lenalidomide_Revlimid Healthcare professional brochure_L04AX04_EU/1/07/391/001-9_6072013
RMM_REVLIMID_lenalidomide_Revlimid Healthcare professional checklist_L04AX04_EU/1/07/391/001-9_6072013
RMM_REVLIMID_lenalidomide_Revlimid Patient Brochure_L04AX04_EU/1/07/391/001-9_6072013
RMM_REVLIMID_lenalidomide_Training acknowledgement form pharmacy_L04AX04_EU/1/07/391/001-9_6072013
RMM_REVLIMID_lenalidomide_Training acknowledgement form physician_L04AX04_EU/1/07/391/001-9_6072013
RMM_REVLIMID_lenalidomide_Treatment Initiation Form Men_L04AX04_EU/1/07/391/001-9_6072013
RMM_REVLIMID_lenalidomide_Treatment Initiation Form WCBP_L04AX04_EU/1/07/391/001-9_6072013
RMM_REVLIMID_lenalidomide_Treatment Initiation Form WNCP_L04AX04_EU/1/07/391/001-9_6072013
RMM_STELARA_ustekinumab_Healthcare professional booklet_L04AC05_EU/1/08/494/001-2_22072013
RMM_STELARA_ustekinumab_Poster for healthcare professionals_L04AC05_EU/1/08/494/001-2_22072013
RMM_STELARA_ustekinumab_Instruction for use calendar - healthcare professional_L04AC05_EU/1/08/494/001-2_22072013
RMM_STELARA_ustekinumab_Instruction for use calendar - patient_L04AC05_EU/1/08/494/001-2_22072013
RMM_STELARA_ustekinumab_Fuljett għal pazjent_L04AC05_EU/1/08/494/001-2_22072013
RMM_STELARA_ustekinumab_Ktejjeb għal pazjent_L04AC05_EU/1/08/494/001-2_22072013
RMM_STELARA_ustekinumab_Patient booklet_L04AC05_EU/1/08/494/001-2_22072013
RMM_STELARA_ustekinumab_Poster għal pazjenti_L04AC05_EU/1/08/494/001-2_22072013
RMM_STELARA_ustekinumab_Poster for patients_L04AC05_EU/1/08/494/001-2_22072013
RMM_NEOTIGASON_acitretin_Fuljett lil Pazjent: Għal Nisa li Jista’ Jkollhom it-Tfal_D05BB02_MA628/04101_5082013
RMM_NEOTIGASON_acitretin_Pregnancy and foetal exposure prevention program_D05BB02_MA628/04101_5082013
RMM_PRADAXA_dabigatran etexilate_Patient alert card_B01AE07_EU/1/08/442/001-019_8082013
RMM_PRADAXA_dabigatran etexilate_SPAF Educational pack_B01AE07_EU/1/08/442/007_011_8082013
RMM_PRADAXA_dabigatran etexilate_SPAF Prescriber guide_B01AE07_EU/1/08/442/007_011_8082013
RMM_PRADAXA_dabigatran etexilate_VTE Educational pack_B01AE07_EU/1/08/442/001_003_005_007_8082013
RMM_PRADAXA_dabigatran etexilate_VTE Prescriber guide_B01AE07_EU/1/08/442/001_003_005_007_8082013
RMM_CUBICIN_daptomycin_A guide to dosing_J01XX09_EU/1/05/328/001-4_28082013
RMM_CUBICIN_daptomycin_Laboratory susceptibility testing leaflet_J01XX09_EU/1/05/328/001-4_28082013
RMM_ROACTEMRA_tocilizumab_MAS card sJ1A_L04AC07_EU/1/08/492/001-6_28082013
RMM_ROACTEMRA_tocilizumab_Patient brochure pJ1A_L04AC07_EU/1/08/492/001-6_28082013
RMM_ROACTEMRA_tocilizumab_Patient brochure sJ1A_L04AC07_EU/1/08/492/001-6_28082013
RMM_ROACTEMRA_tocilizumab_pJ1A healthcare professional brochure_L04AC07_EU/1/08/492/001-6_28082013
RMM_ROACTEMRA_tocilizumab_pJ1A pocket dosing guide_L04AC07_EU/1/08/492/001-6_28082013
RMM_ROACTEMRA_tocilizumab_pJ1A sJ1A patient alert card_L04AC07_EU/1/08/492/001-6_28082013
RMM_ROACTEMRA_tocilizumab_pJ1A Step-by-step dosing and administration guide_L04AC07_EU/1/08/492/001-6_28082013
RMM_ROACTEMRA_tocilizumab_Pocket dosing guide RA_L04AC07_EU/1/08/492/001-6_28082013
RMM_ROACTEMRA_tocilizumab_RA healthcare professional brochure_L04AC07_EU/1/08/492/001-6_28082013
RMM_ROACTEMRA_tocilizumab_RA patient brochure_L04AC07_EU/1/08/492/001-6_28082013
RMM_ROACTEMRA_tocilizumab_RA step-by-step dosing guide_L04AC07_EU/1/08/492/001-6_28082013
RMM_ROACTEMRA_tocilizumab_sJ1A healthcare professional brochure_L04AC07_EU/1/08/492/001-6_28082013
RMM_ROACTEMRA_tocilizumab_sJ1A pocket dosing guide_L04AC07_EU/1/08/492/001-6_28082013
RMM_ROACTEMRA_tocilizumab_sJ1A step-by-step dosing and administration guide_L04AC07_EU/1/08/492/001-6_28082013
RMM_EYLEA_aflibercept_Patient Booklet_S01LA05_EU/1/12/797/001-2_19092013
RMM_INFLECTRA_infliximab_IBD management in Children Safety Information_L04AB02_EU/1/13/854/001-5_19092013
RMM_INFLECTRA_infliximab_Infusion Card_L04AB02_EU/1/13/854/001-5_19092013
RMM_INFLECTRA_infliximab_Safety information for prescribing physicians_L04AB02_EU/1/13/854/001-5_19092013
RMM_INFLECTRA_infliximab_Screening sheet_L04AB02_EU/1/13/854/001-5_19092013
RMM_XALKORI_crizotinib_Educational material for healthcare professionals_L01XE16_EU/1/12/793/001-4_23102013
RMM_MIRCERA_methyoxy polyethylene glycol-epoetin beta_Physicians guide for diagnosing and reporting adverse drug reactions with Mircera_B03XA03_EU/1/07/400/008-022_24102013
RMM_CONCERTA_methylphenidate hydrochloride_Ċart għall-monitoraġġ kontinwu waqt il-kura b'methylphenidate (MPH)_N06BA04_MA018/02601-3_RITALIN_methylphenidate hydrochloride_Ċart għall-monitoraġġ kontinwu waqt il-kura b'methylphenidate (MPH)_N06BA04_MA1249/01801_31102013
RMM_CONCERTA_methylphenidate_hydrochloride_Il-gwida ta' preskrizzjoni għat-tobba_N06BA04_MA018/02601-3_RITALIN_methylphenidate hydrochloride_Il-gwida ta' preskrizzjoni għat-tobba_N06BA04_MA1249/01801_31102013
RMM_CONCERTA_methylphenidate hydrochloride_Lista ta' kontroll għall-monitoraġġ ta' terapija kontinwu_N06BA04_MA018/02601-3_RITALIN_meylphenidate hydrochloride_Lista ta' kontroll għall-monitoraġġ ta terapija kontinwu_N06BA04_MA1249/01801_31102013
RMM_LUCENTIS_ranibizumab_CNV Audio CD Script_S01LA04_EU/1/06/374/001-4_31102013
RMM_LUCENTIS_ranibizumab_CNV patient booklet_S01LA04_EU/1/06/374/001-4_31102013
RMM_LUCENTIS_ranibizumab_Physician leaflet_S01LA04_EU/1/06/374/001-4_31102013
RMM_TASIGNA_nilotinib_Healthcare professional brochure_L01XE08_EU/1/07/422/001-14_06112013
RMM_TASIGNA_nilotinib_Patient brochure_L01XE08_EU/1/07/422/001-14_06112013
RMM_JETREA_ocriplasmin_Patient brochure_S01XA22_EU/1/13/819/001_13112013
RMM_ZIAGEN_abacavir_Training presentation for healthcare professional_J05AF06_EU/1/99/112/001-2_29112013
RMM_YERVOY_ipilimumab_Healthcare professional FAQ brochure_L01XC11_EU/1/11/698/001-2_19122013
RMM_YERVOY_ipilimumab_Patient alert card_L01XC11_EU/1/11/698/001-2_19122013
RMM_YERVOY_ipilimumab_Patient information brochure_L01XC11_EU/1/11/698/001-2_19122013
RMM_ERIVEDGE_vismodegib_PPP Healthcare professional brochure_L01XX43_EU/1/13/848/001_20122013
RMM_ERIVEDGE_vismodegib_PPP Healthcare professional reminder card_L01XX43_EU/1/13/848/001_20122013
RMM_ERIVEDGE_vismodegib_PPP Patient brochure_L01XX43_EU/1/13/848/001_20122013
RMM_ERIVEDGE_vismodegib_PPP Patient reminder card_L01XX43_EU/1/13/848/001_20122013
RMM_ERIVEDGE_vismodegib_PPP Verification counselling form_L01XX43_EU/1/13/848/001_20122013
RMM_EXELON_rivastigmine hydrogen tartrate_Patient Diary_N06DA03_EU/1/98/066/019-034_23122013
RMM_PIOGLITAZONE ACTAVIS_pioglitazone_Educational pack_A10BG03_EU/1/12/755/001-9_26032012
RMM_LUCENTIS_ranibizumab_Patient Booklet RVO_S01LA04_EU/1/06/374/001-4_10042012
RMM_TROBALT_retigabine_Physicians guide_N03AX21_EU/1/11/681/001-013_22052012
RMM_ACLASTA_zoledronic acid_Physician guide_M05BA08_EU/1/05/308/001-2_06062012
RMM_ACLASTA_zoledronic acid_Patient guide_M05BA08_EU/1/05/308/001-2_06062012
RMM_INCIVO_telaprevir_Physician Leaflet_J05AE11_EU/1/11/720/001-2_19062012
RMM_INCIVO_telaprevir_Safety overview_J05AE11_EU/1/11/720/001-2_19062012
RMM_NEBIDO_testosterone undecanoate_Information for healthcare professionals_G03BA03_MA185/02701_24072012
RMM_MABTHERA_rituximab_Healthcare professionals information_L01XC02_EU/1/98/067/001_15112012
RMM_MABTHERA_rituximab_Patient leaflet_L01XC02_EU/1/98/067/001_15112012
RMM_XARELTO_rivaroxaban_Patient card_B01AF01_EU/1/08/472/001-39_19112012
RMM_XARELTO_rivaroxaban_Prescriber guide_B01AF01_EU/1/08/472/001-39_19112012
RMM_ROACTEMRA_tocilizumab_Step-by-Step Infusion Guide_L04AC07_EU/1/08/492/001-6_20112012
RMM_ROACTEMRA_tocilizumab_MAS card_L04AC07_EU/1/08/492/001-6_20112012
RMM_ROACTEMRA_tocilizumab_sJIA_Healthcare professional brochure_L04AC07_EU/1/08/492/001-6_20112012
RMM_ROACTEMRA_tocilizumab_sJIA_Alert Card _L04AC07_EU/1/08/492/001-6_20112012
RMM_ROACTEMRA_tocilizumab_sJIA Step-by-Step infusion guide_L04AC07_EU/1/08/492/001-6_20112012
RMM_ROACTEMRA_tocilizumab_Patient brochure_L04AC07_EU/1/08/492/001-6_20112012
RMM_ROACTEMRA_tocilizumab_Healthcare professional brochure_L04AC07_EU/1/08/492/001-6_20112012
RMM_ROACTEMRA_tocilizumab_Pocket dosing guide_L04AC07_EU/1/08/492/001-6_20112012
RMM_ROACTEMRA_tocilizumab_Dosing Card sJIA_L04AC07_EU/1/08/492/001-6_20112012
RMM_ROACTEMRA_tocilizumab_Patient brochure sJIA_L04AC07_EU/1/08/492/001-6_20112012
RMM_EYLEA_aflibercept_Prescriber guide_S01LA05_EU/1/12/797/001-2_22112012
RMM_EYLEA_aflibercept_Patient booklet_S01LA05_EU/1/12/797/001-2_22112012
RMM_VALDOXAN_agomelatine_Physician guide_N06AX22_EU/1/08/499/001-008_22112012
RMM_VALDOXAN_agomelatine_Liver function monitoring scheme_N06AX22_EU/1/08/499/001-008_22112012
RMM_PRADAXA_dabigatran etexilate_Patient alert card_B01AE07_EU/1/08/442/001-019_23112012
RMM_PRADAXA_dabigatran etexilate_SPAF Educational pack_B01AE07_EU/1/08/442/001-019_23112012
RMM_PRADAXA_dabigatran etexilate_SPAF Prescriber guide_B01AE07_EU/1/08/442/001-019_23112012
RMM_PRADAXA_dabigatran etexilate_VTE Educational pack_B01AE07_EU/1/08/442/001-019_23112012
RMM_PRADAXA_dabigatran etexilate_VTE Prescriber guide_B01AE07_EU/1/08/442/001-019_23112012
RMM_MULTAQ_dronedarone_Information Card_C01BD07_EU/1/09/591/001-4_03122012
RMM_MULTAQ_dronedarone_Prescriber Checklist_C01BD07_EU/1/09/591/001-4_03122012
RMM_VIREAD_tenofovir disoproxil fumarate_HBV renal educational brochure_J05AF07_EU/1/01/200/001-9_03122012
RMM_VIREAD_tenofovir disoproxil fumarate_HIV renal educational brochure_J05AF07_EU/1/01/200/001-9_03122012
RMM_VELCADE_bortezomib_Reconstitution poster_L01XX32_EU/1/04/274/001_18122012
RMM_VELCADE_bortezomib_Dosing slide rule_L01XX32_EU/1/04/274/001_18122012
RMM_VELCADE_bortezomib_Reconstitution guide_L01XX32_EU/1/04/274/001_18122012
RMM_REVLIMID_lenalidomide_Healthcare Professional Brochure_L04AX04_EU/1/07/391/001-9_18022011
RMM_REVLIMID_lenalidomide_Patient Brochure WCBP_L04AX04_EU/1/07/391/001-9_18022011
RMM_REVLIMID_lenalidomide_Patient Brochure WNCBP_L04AX04_EU/1/07/391/001-9_18022011
RMM_ROACTEMRA_tocilizumab_Healthcare Professional Brochure_L04AC07_EU/1/08/492/001_03_05_05042011
RMM_ROACTEMRA_tocilizumab_MAS Card Malta_L04AC07_EU/1/08/492/001_03_05_05042011
RMM_ROACTEMRA_tocilizumab_Patient alert card_L04AC07_EU/1/08/492/001-6_05042011
RMM_ROACTEMRA_tocilizumab_Patient Brochure sJIA Malta_L04AC07_EU/1/08/492/001-6_05042011
RMM_ROACTEMRA_tocilizumab_Pocket dosing guide for systemic juvenile idiopathic arthritis (sJIA)_L04AC07_EU/1/08/492/001_03_05_05042011
RMM_ROACTEMRA_tocilizumab_RoActemra sJIA Patient alert card_L04AC07_EU/1/08/492/001-6_05042011
RMM_ROACTEMRA_tocilizumab_Dosing and administration guide_L04AC07_EU/1/08/492/001_03_05_05042011
RMM_LUCENTIS_ranibizumab_Patient Booklet_S01LA04_EU/1/06/374/001-4_13072011
RMM_TASIGNA_nilotinib_Patient brochure_L01XE08_EU/1/07/422/001-14_30092011
RMM_PRADAXA_dabigatran etexilate_Patient alert card_B01AE07_EU/1/08/442/001-019_03102011
RMM_PRADAXA_dabigatran etexilate_SPAF Educational Pack_B01AE07_EU/1/08/442/007_011_03102011
RMM_PRADAXA_dabigatran etexilate_SPAF Prescriber guide_B01AE07_EU/1/08/442/007_011_03102011
RMM_PRADAXA_dabigatran etexilate_VTE Educational Pack_B01AE07_EU/1/08/442/001_003_005_007_03102011
RMM_PRADAXA_dabigatran etexilate_VTE Prescriber guide_B01AE07_EU/1/08/442/001_003_005_007_03102011
RMM_GILENYA_fingolimod_Patient reminder card_L04AA27_EU/1/11/677/001-6_17102011
RMM_GILENYA_fingolimod_Kartuna li tfakkar lill-pazjent_L04AA27_EU/1/11/677/001-6_17102011
RMM_MULTAQ_dronedarone_MULTAQ Information Card_C01BD07_EU/1/09/591/001-4_24102011
RMM_MULTAQ_dronedarone_Prescriber Checklist_C01BD07_EU/1/09/591/001-4_24102011
RMM_XARELTO_rivaroxaban_Karta tal-pazjent_B01AF01_EU/1/08/472/001-39_03112011
RMM_XARELTO_rivaroxaban_Patient card_B01AF01_EU/1/08/472/001-39_03112011
RMM_XARELTO_rivaroxaban_Prescriber guide_B01AF01_EU/1/08/472/001-39_03112011
RMM_REVLIMID_lenalidomide_Patient Card_L04AX04_EU/1/07/391/001-9_28052010
RMM_REVLIMID_lenalidomide_Pregnancy Capture Form_L04AX04_EU/1/07/391/001-9_28052010
RMM_REVLIMID_lenalidomide_Treatment Initiation Form Men_L04AX04_EU/1/07/391/001-9_28052010
RMM_REVLIMID_lenalidomide_Treatment Initiation Form WCBP_L04AX04_EU/1/07/391/001-9_28052010
RMM_REVLIMID_lenalidomide_Treatment Initiation Form WNCBP_L04AX04_EU/1/07/391/001-9_28052010
RMM_ARAVA_leflunomide_Physician leaflet_L04AA13_EU/1/99/118/001-010_09092010
RMM_ARAVA_leflunomide_Patient leaflet_L04AA13_EU/1/99/118/001-010_09092010